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Abstract 
 In this dissertation, three separate but related studies describe opioid use by injured 
workers in TN, identify patterns of opioid use by injured workers that are associated with 
nonfatal overdose, and develop a predictive model for the development of long-term opioid use 
in injured workers who were opioid-free at the time of injury. These studies link statewide 
databases to connect Workers’ Compensation records of injured workers to their prescription 
history in TN’s prescription drug monitoring program, hospital and emergency room records in 
TN’s Hospital Discharge Data System, and death certificates in TN’s Vital Statistics death 
certificates dataset. In a cross-sectional study, the prevalence of opioid use in injured workers is 
calculated and Poisson regression is used to assess prevalence ratios of the association between 
demographic and injury variables with opioid use. In a case-control study, the incidence of 
nonfatal overdose is calculated and conditional logistic regression is used to examine 
demographic, injury, and opioid use patterns that are associated with overdose. In a cohort study, 
unconditional logistic regression is used to build a predictive model of demographic, injury, and 
opioid use patterns that are associated with the development of long-term opioid use in 
previously opioid-free injured workers. These studies found that opioid use is widespread in 
injured workers after injury, but occurs largely within limits set by prescribing guidelines and 
tends to be discontinued within a month or two. Overdose and the development of long-term 
opioid use are rare, but affect vulnerable subsets of the population which may benefit from a 
different prevention and treatment approach than the overall population. 
 
These studies were supported by funding from the Centers for Disease Control and Prevention’s 
Prescription Drug Overdose: Prevention for States program, grant number 5 NU17CE002731-
02-00
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Chapter 1 Introduction  
Background 
When scored with a razor, the unripe seed pods of the poppy Papaver Somniferum, which 
the Sumerians called Hul Gil or “flower of joy” seep a milky latex sap that turns fragrant and 
tarry when dried (Public Broadcasting Service, 1998). This is opium, which exerts such a 
powerful control over those who taste it that it has been cultivated for over 4000 years, 
associated with gods in the ancient world, and caused wars between modern civilizations (Katz, 
2007; Pletcher, 2015). Today, drugs derived from or based on opium are at the center of the 
worst iatrogenic problem of our time: the opioid epidemic.  
Context of the opioid epidemic. 
Opioids were the leading cause of injury in the United States (U.S.) at the time this 
dissertation was written (U.S. Department of Health and Human Services, 2017), but the roots of 
the epidemic lie several decades earlier. In the 1980s, a campaign led by the American Society of 
Anesthesiologists touting the alleged undertreatment of pain began a national discourse on the 
right to pain relief. Where opioids had previously been reserved for end-of-life care, extreme 
trauma, and surgery, this campaign advocated for pain assessment at every patient visit and 
designated pain as the “fifth vital sign” (Morone & Weiner, 2013). Pain treatment as a normal 
part of patient-provider interactions became ratified in guidelines by the American Pain Society 
in 1995 and the Joint Commission on Accreditation of Health Care in 2000, and patient self-
reported pain was incorporated into hospital quality control measures (Morone & Weiner, 2013; 
National Pharmaceutical Council). This lobbying by professional organizations was 
accompanied by a massive and misleading marketing campaign by pharmaceutical companies, 
led by Purdue Pharma as the owner of Oxycontin, with the result that opioid prescribing, and 
use, became normalized for many diverse types of pain (Alam & Juurlink, 2016). The abrupt 
flourishing of opioids occurred despite a lack of robust evidence signifying their safety, and 
subsequent research quantifying their harms failed to prevent the epidemic.  
National trends. 
 Trends in the opioid epidemic are tracked with two main measures: opioid prescribing 
rates and opioid overdose rates. Nationally, opioid prescribing peaked in 2012 at 81.3 
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prescriptions per 100 persons and declined to a 10-year low in 2016 at 66.5 prescriptions per 100 
persons (Prevention). In 2016, the average daily dose per opioid prescription was 47.1 morphine 
milligram equivalents (MMEs) and the prescribing rate of high dosage opioids (≥90 daily 
MMEs) was 6.1 per 100 persons (Centers for Disease Control and Prevention, 2017). While 
prescribing rates are decreasing, however, rates of overdose continue to increase exponentially 
(Centers for Disease Control and Prevention, Opioid Data Analysis). In 2015, the age-adjusted 
opioid-involved mortality rate was 10.4 deaths per 100,000 persons, a 15.6% increase from the 
rate in 2014 of 9.0 deaths per 100,000 persons (Rudd, Seth, David, & Scholl, 2016). This 
acceleration appears to be driven by increases in overdoses on heroin and synthetic opioids like 
fentanyl that have been linked to illicit markets (National Institute on Drug Abuse, 2017). These 
measures do not fully capture the scale of the epidemic, and survey data indicates that tens of 
millions of people use illicit drugs or misuse prescription drugs every year in the U.S.. In 2015, 
an estimated 4.7% of adults over the age of 12 reported having used prescription pain relievers 
nonmedically in the past year (Substance Abuse and Mental Health Services Administration, 
2016).  
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Figure 1.1: Overdose deaths involving opioids by type of opioid, United States 2000-2016  
 
Figure source: Centers for Disease Control and Prevention, Prescription drug overdose: 
Understanding the epidemic: Data overview, 2017 
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Tennessee trends. 
Tennessee (TN) is among the hardest-hit states in the U.S. by the epidemic, with the 
third-highest prescribing rate of opioids (107.5 opioid prescriptions per 100 persons in 2016). 
Compared to other U.S. states, TN has the second highest rate of prescribing long-acting opioids 
(11.0 prescriptions per 100 persons) and the fifth highest rate of prescribing high-dosage opioids 
(≥90 daily morphine milligram equivalents, rate=9.8 prescriptions per 100 persons). Like the 
overall U.S., TN’s prescribing rate has decreased over the past few years, from 127.1 
prescriptions per 100 persons in 2014 to 107.5 in 2016 (Centers for Disease Control and 
Prevention, U.S. State Prescribing Rates). TN’s opioid overdose rate shows the same 
accelerating trend in overdoses as the overall U.S., and TN is one of twenty five states driving 
national increases. In TN, the opioid overdose age-adjusted mortality rate increased by 10.4% 
from 22.2 deaths per 100,000 persons in 2015 to 24.5 in 2016 (Centers for Disease Control and 
Prevention, 2017). 2016 was the worst year on record for opioid overdoses in TN, with 1,186 
opioid overdose deaths, 13,034 overdose outpatient admissions (rate=197.5 per 100,000 
persons), and 7,072 inpatient admissions (rate=107.4 per 100,000 persons) (Tennessee 
Department of Health, Data Dashboard). In 2012-2014, an estimated 4.18% of Tennessee adults 
over the age of 12 reported using prescription pain relievers nonmedically in the past year 
(Substance Abuse and Mental Health Services Administration, State and substate estimates of 
nonmedical use of prescription pain relievers, 2017).  
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Figure 1.2: All drug and opioid overdose deaths, Tennessee 2012-2016 
 
Figure source: Tennessee Department of Health, Data Dashboard 
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Opioids and injured workers. 
What is known. 
Injured workers are a population with special needs for the treatment of pain, where pain 
management and rehabilitation are sometimes competing aims (Lai, Szeto, & Chan, 2017). As 
Newton-John and McDonald describe, “The clinical management of chronic pain is a 
biopsychosocial challenge in itself; however, when the pain occurs in the context of workers 
compensation, there is even greater clinical complexity” (Newton-John & McDonald, 2012). The 
Workers’ Compensation (WC) and Social Security Disability systems add an additional layer of 
complexity by providing an incentive to emphasize pain and downplay improvement in some 
cases (Harris, Mulford, Solomon, van Gelder, & Young, 2005). 
Research on opioid use by injured workers typically relies on WC records, which only 
measure opioids that are paid for by WC and dispensed to approved claimants. These data 
sources (every state has its own) show that opioid use is widespread in claimants. Prevalences of 
receiving an opioid vary across the nation, ranging from 19.2% of claimants receiving an opioid 
during the time that their claim was open in Ohio to 46.4% receiving an opioid within one year 
of injury in Louisiana (Dembe, Wickizer, Sieck, Partridge, & Balchick, 2012; Lavin, Tao, 
Yuspeh, & Bernacki, 2014). Opioids given to WC claimants tend to be prescribed early in 
therapy and in high doses (Bernacki, Yuspeh, Lavin, & Tao, 2012; Franklin, Stover, Turner, 
Fulton-Kehoe, & Wickizer, 2008). In Washington State in 2002-2003, 52% of claimants who 
received opioids got that opioid at their first medical visit (Stover, Turner, Franklin, Gluck, 
Fulton-Kehoe et al., 2006). In a large, combined sample of U.S. WC claimants with low back 
pain, the median time that opioids were initiated was eight days after the first medical visit, and 
9.4% of claimants who received an opioid got a potent long-acting formula within two years of 
injury (Cifuentes, Webster, Genevay, & Pransky, 2010). 
Among injured workers, recent research indicates that the receipt of an opioid for pain is 
not associated with improved outcome. On the contrary, there is a trend of earlier prescribing of 
opioids leading to longer disability and higher costs in WC claimants (Franklin et al., 2008; 
Gross, Stephens, Bhambhani, Haykowsky, Bostick et al., 2009; Volinn, Fargo, & Fine, 2009; 
Webster, Verma, & Gatchel, 2007) even when baseline disability, pain, duration of symptoms, 
coping style, and pain self-efficacy are controlled for (Ashworth, Green, Dunn, & Jordan, 2013). 
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Knowledge gaps. 
 As opioid use has changed in the overall population over the past five to ten years, there 
is a lack of recent estimates of opioid use by injured workers to keep the field current. 
Additionally, previous estimates made using WC records likely underestimate the true extent of 
opioid use by injured workers because the high variance in which claims are accepted by WC, 
the presence of multiple provider episodes (a patient visiting multiple prescribers in order to gain 
access to greater levels of controlled substances), and long periods between the date of injury and 
date of claim approval introduce opioids that are unaccounted for in WC records. These 
additional sources of opioids bias estimates of opioid use prevalence and associations that are 
made with WC records alone. 
Tennessee-specific knowledge gaps. 
Opioid use prevalence and mortality have been researched by the TN Department of 
Health for the overall population, but no one has examined opioids in injured workers in TN. 
This topic has only been researched in a few states in the U.S., and high inter-state variability in 
culture and opioid use trends (Webster, Cifuentes, Verma, & Pransky, 2009) limit the extent to 
which findings from other states can be generalized. TN is a forerunner in pioneering opioid 
analyses using a prescription drug monitoring program, but neither baseline rates nor 
associations and trends of opioid use by injured workers are known.  
Innovation 
The studies included in this dissertation are the first in TN to study opioid use by injured 
workers and among the first nationally to use a prescription drug monitoring program for this 
purpose. TN’s prescription drug monitoring program includes a record of every prescription for 
opioids and other controlled substances that are dispensed legally in Tennessee, and provides an 
opportunity for a much more comprehensive picture of opioid use than WC records alone are 
capable of. Using a prescription drug monitoring program allows for higher accuracy of 
estimates, and richer detail in analyses of the correlates and outcomes of opioid use. This is 
important to study in TN because, although the rate of opioid use by injured workers is unknown, 
high opioid use and misuse by the overall population indicate that use and misuse may also be 
high for this group. A greater understanding of the landscape and context of opioid use by 
injured workers in Tennessee is needed in order to protect individual and community health and 
allocate state resources to the areas of greatest need. The studies in this dissertation provide a 
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previously unavailable picture of the prevalence, patterns, and outcomes of the opioid epidemic 
in this population.  
Purpose of this dissertation 
 This dissertation presents three separate but related studies to 1) describe opioid use by 
injured workers in TN, 2) identify patterns of opioid use by injured workers that are associated 
with nonfatal overdose, and 3) develop a predictive model for the development of long-term 
opioid use in injured workers who were opioid-free at the time of injury.  
Research questions 
 Chapter 2 - Prescription opioid use by injured workers: A descriptive study using 
linked statewide databases in Tennessee.  
Cross sectional study 
Research questions (RQs): 
RQ 2.1: What is the percentage of injured workers who receive opioids within one week, one 
month, and six months of injury from 2013 through 2015? 
Hypothesis: Tennessee falls in the upper range of states for opioid use by injured workers 
with the percentage receiving an opioid use after injury of  >20% within one week, >25% 
within one month, and >30% within six months.  
RQ 2.2: Do injured workers who received opioids in the six months after injury differ by sex, 
age, residence area, or injury type compared to the injured workers who did not receive opioids? 
Hypothesis: Men, people of middle age groups, people living in east Tennessee, and 
people with more traumatic injuries have higher prevalence of receiving opioids (PR>1). 
Sex and age interact so that middle aged women have greater prevalence ratio than other 
sex and age groups of receiving opioids (PR of the interaction >1), and age and injury 
type interact so that older people with more traumatic injuries have higher prevalence 
ratio of receiving opioids (PR of the interaction>1) than people with less traumatic 
injuries. 
RQ 2.3: Among injured workers with one or more opioid prescriptions in the first six months 
after injury, what is the percentage who experienced any of five key high-risk patterns of opioid 
use compared to not experiencing that pattern: receiving greater than 80 mean daily morphine 
milligram equivalents (MMEs), receiving greater than 100 mean daily MMEs, combined opioid 
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and benzodiazepine use, receiving a long-acting opioid, and having a multiple provider episode 
from 2013 through 2015? 
Hypothesis: Among injured workers who received opioids, the percentage receiving 
greater than 80 mean daily MMEs, combined opioid and benzodiazepine use, and a long-
acting opioid are high (30%) while the proportion receiving greater than 100 mean daily 
MMEs is lower but still high (20%) and the proportions with a multiple provider episode 
is low but still present (10%). 
Chapter 3 - Patterns of prescription opioid use associated with nonfatal opioid 
overdose: A case-control study using linked statewide databases in Tennessee.  
Nested case-control study 
Research questions (RQs): 
RQ 3.1: How do the incidence rates of nonfatal opioid-involved overdose amongst injured 
workers compare to the incidence rates in the general population of Tennessee? 
Hypothesis: Opioid-involved overdoses are less common in injured workers than in the 
general population (incidence rate ratios <1). 
RQ 3.2: What are the associations of type of injury, early initiation of opioid therapy, prior 
history of opioid use, long-acting opioids, cash payment, combined opioid and benzodiazepine 
use, and multiple provider episodes with the odds of nonfatal overdose amongst injured workers 
with one or more opioid prescriptions? 
Hypothesis: More traumatic injuries, early initiation of opioid therapy, prior history of 
opioid use, long-acting opioids, cash payment, combined opioid and benzodiazepine use, 
and multiple provider episodes are associated with nonfatal overdose (OR>1). 
RQ 3.3: Is mean daily morphine milligram equivalents (MME) a mediator in the associations 
between type of injury, early initiation of opioid therapy, prior history of opioid use, long-acting 
opioids, cash payment, combined opioid and benzodiazepine use, and multiple provider episodes 
and the odds of nonfatal overdose amongst injured workers with one or more opioid 
prescriptions? 
Hypothesis: Mean daily MME partially mediates the associations between more 
traumatic injuries, early initiation of opioid therapy, prior history of opioid use, long-
acting opioids, cash payment, combined opioid and benzodiazepine use, and multiple 
provider episodes and the odds of nonfatal overdose (MME is associated with overdose 
   
 
10 
 
with OR>1 and ORs of other variables decrease but do not reach null after the inclusion 
of MME in the model).  
Chapter 4 - A predictive model for injury as a gateway to long-term opioid use: A 
retrospective cohort study using linked statewide databases in Tennessee.  
Cohort study 
Research questions (RQs): 
RQ 4.1: What percentage of injured workers are opioid-free at the time of their injury? 
Hypothesis: More than half (>50%) of injured workers are opioid-free at the time of their 
injury. 
RQ 4.2: Among injured workers who were opioid-free at the time of injury but who received an 
opioid in the month after injury, does a three or four month follow-up period capture more cases 
of long-term opioid use?  
Hypothesis: Measuring opioid use as receiving an opioid on most days in a four month 
period captures more cases than measuring opioid use as receiving an opioid on most 
days in a three month period.  
RQ 4.3: What demographic factors (sex, age, residence area, injury type, and part of body 
injured) and opioid use patterns (early initiation of opioid therapy, combined opioid and 
benzodiazepine use, long-acting opioids, higher mean daily MME, higher day’s supply, multiple 
prescribers and pharmacies, cash payment) predict a previously opioid-free injured worker 
developing long-term opioid use after injury? 
Hypothesis: Female sex, middle age group, residence in east TN, more traumatic injuries, 
early initiation of opioid therapy, long-acting opioids, higher mean daily MME, using 
multiple prescribers and pharmacies, and cash payment predict long-term opioid use 
(ORs>1). Part of body injured does not predict long-term opioid use (OR=1).  
Main Data Sources 
The following data sources will be used in the proposed set of three research studies. All data 
sources will be accessed through a Health Enterprise Warehouse maintained by the TN 
Department of Health.  
Workers’ Compensation (WC) Records. 
 WC is an employer-buy in insurance program that pays medical care costs and wage 
replacement for employees who are injured at work. In TN, WC is mandatory for all construction 
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and coal-mining employers and for nongovernmental employers with greater than 5 employees. 
WC is optional for government agencies (state and local) and employers of farm laborers or 
domestic help. The percentage of businesses covered by WC in TN is unknown. WC records are 
kept in a database by the Bureau of Workers’ Compensation in the Tennessee Department of 
Labor and Workforce Development. The records that form the database used by these studies are 
drawn from the “Employer’s First Report of Work Injury or Illness” form, which employers are 
required to submit within 30 days for illnesses and injuries occurring in the workplace (Appendix 
1). Submission of this form is mandatory even if the injured worker does not intend to seek care 
or compensation, but exempt if the illness or injury requires only first aid to treat. 
Underreporting of workplaces injuries is estimated to be as high as 66% (United States. Cong. 
House. Committee on Energy and Commerce Subcommittee on Oversight and Investigation, 
2014). This estimate is likely inflated by the huge number of superficial and minor injuries 
(which would not require opioids for treatment), but employers may also be incentivized to 
underreport injuries in order to avoid paperwork and negative attention (Wuellner, Adams, & 
Bonauto, 2016). There has not been any research in TN on the extent of underreporting. 
Electronic records of years 2013-2015 of the “Employer’s First Report of Work Injury or 
Illness” form were shared by the TN Department of Labor for this research. In this form, workers 
are identified with social security number, name, and date of birth. The form includes mandatory 
and optional fields. In the electronic database that was used for research, mandatory fields had 
≤0.02% missing data and optional fields had 16.7% - 100% missing data. To avoid reporting 
bias, these studies only analyzed mandatory reporting variables. Marital status, an optional 
variable, was occasionally included for descriptive purposes.  
Controlled Substances Monitoring Database (CSMD). 
 The CSMD is a database that monitors every controlled substance that is legally 
dispensed in TN and is kept by the Controlled Substance Monitoring Database Program in the 
TN Department of Health. The CSMD contains drug, patient, prescriber, and dispenser 
information to capture detailed information on every controlled substance given to every patient. 
Prescription information that is collected includes the date the prescription was written, the date 
the prescription was filled, the name, type, and schedule of the drug, the dose and days’ supply, 
the method of payment, the address and identifier of the prescriber, the address  and identifier of 
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the pharmacist, and the address and identifier of the patient. This detail of prescription 
information is a key strength of the studies outlined in this paper.  
The CSMD was established in 2002 and data entry by dispensers was made mandatory in 
2006 (TN Department of Health “Controlled substance”). However, due to slow uptake and lack 
of funding, data quality is poor prior to 2012. For years 2013 and later (after implementation of 
the Prescription Safety Act of 2012 which reaffirmed required use of the CSMD and funded 
maintenance for the database), the CSMD is considered to be a near-complete record of 
controlled substances dispensed in TN. There are several instances where a prescription would 
not be entered in the CSMD, including: 1) controlled substances dispensed by some licensed 
physician-dispensers through their office instead of through a pharmacy, 2) prescriptions that are 
written in TN but filled out-of-state, and 3) controlled substances dispensed through military 
sources or narcotic treatment programs. However, these instances are estimated to be less than 
1% of the total number of prescriptions filled through pharmacies in the state. 
Patients are identified in the CSMD with name and date of birth rather than with social 
security number or another unique identifier, leading to challenges in matching people to their 
prescriptions. For these studies, injured workers were linked to the CSMD on cleaned and 
standardized first name, last name, and date of birth.   
Hospital Discharge Data System (HDDS). 
 HDDS is a billing log of inpatient and outpatient treatment provided to patients at all 
hospitals licensed by the TN Department of Health. HDDS includes data for patients seen in 
emergency rooms but does not include data for patients seen at private clinics located outside of 
hospitals. HDDS is used nationwide and TN records are held by the TN Department of Health. 
HDDS includes information on patient, injury or illness, and treatment. Diagnoses are recorded 
with ICD-9 codes prior to the third quarter of 2015, and ICD-10 codes after. HDDS is a complete 
or near-complete record of hospital visits due to legally required reporting and the use of 
mandatory fields, but has some error due to misdiagnoses, incorrect identification of 
procedure/patient/site, and data entry errors. Challenges using HDDS include underestimation of 
counts and rates due to people who did not seek care at a hospital and misestimates of counts and 
rates due to misdiagnoses. For example, someone who had cardiac arrest caused by a drug 
overdose may be coded only as “cardiac arrest.” In HDDS, patients are identified with social 
security number. 
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Vital Statistics Death Certificates. 
 Vital Statistics death certificates is a database of death certificate records for every 
decedent who was a resident of TN or who died in TN. Death certificates have been recorded 
electronically in TN since at least 2002, but major changes to the format of variables occurred in 
2012. This study will use data collected after 2012. Vital demographics (e.g. age, race/ethnicity, 
education, income, marital status), residence, location of death, and cause of death information is 
collected by medical examiners, coroners, and local health departments and reported using a 
standard form (Appendix 1). After initial receipt by the Department of Health, death certificate 
records are revised according to autopsy findings and hospital records if needed before being 
made available for research. Vital Statistics death data is kept by the Office of Policy, Planning, 
and Assessment in the TN Department of Health. Decedents are identified with social security 
number. Vital Statistics death certificates are considered to be the best currently available record 
of everyone who died in TN, although validation studies have shown that overdose deaths are 
often underestimated due to underreporting and not specifying a type of drug. Nationwide, 
approximately 25% of overdose deaths do not specify a drug on the death certificate (Slavova et. 
al., 2015).  
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Chapter 2 
 Prescription opioid use by injured workers: A descriptive study using linked statewide 
databases in Tennessee. 
Abstract 
Background  Injured workers bear a high burden of opioid use in southern and central states of 
the U.S., putting them at risk for drug dependence, delayed recovery, and other opioid-associated 
adverse effects. Research from other states shows that opioid use after injury is high, but 
previous estimates conducted with Workers’ Compensation (WC) records do not capture opioid 
use in injured workers who do not become claimants. A prescription drug monitoring program 
was used to measure opioid use in Tennessee (TN) injured workers who reported an injury to 
WC and describe trends in prescribing and the demographic and clinical characteristics of opioid 
users. This is the first study in TN to measure opioid use in injured workers and among the first 
nationally to use a prescription drug monitoring program to do so.   
Objective  A retrospective cohort study was conducted to evaluate the prevalence of filling an 
opioid prescription after injury and associated demographics and injury characteristics among 
workers who reported an injury to the TN Bureau of WC during 2013-2015. 
Methods  Injured workers identified in WC first report of injury forms 2013-2015 were linked to 
their prescription history in Tennessee’s prescription drug monitoring database. Percentages of 
receiving an opioid within 1 week, 1 month, and 6 months, of injury were calculated by year. 
Associations between demographics and injury characteristics and receiving an opioid were 
assessed with Poisson regression. Among injured workers who received opioids within 6 months 
of injury the following patterns of opioid use were described: dose, days’ supply, number of 
prescribers and dispensers visited, type of opioid, type of payment, receiving an opioid within 30 
days of a benzodiazepine, receiving >100 mean daily morphine milligram equivalents, receiving 
a long-acting opioid, and having a multiple provider episode (≥3 prescribers and ≥3 dispensers in 
the 180 days after injury), and type of benzodiazepine.   
Results  This study included 172,256 injured workers who reported only one injury during 2013-
2015. Injured workers were predominantly male (55.3%) and aged 35-54 years (43.5%). The 
prevalence of receiving an opioid after injury was 22.8% in 1 week, 29.7% in 1 month, and 
33.3% in 6 months across all years. Receiving an opioid was associated with having a fracture 
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(prevalence ratio [PR]=2.3, 95% confidence interval [CI] 2.22-2.36 vs. non-fracture, non-strain 
sprain or tear injuries) and having a record for opioid use prior to injury (PR=2.3, 95% CI 2.29-
2.39 vs. no prior opioid use). Among people who received an opioid, the mean maximum dose 
received was 42.8 daily morphine milligram equivalents (standard deviation 39.26). 
Hydrocodone short-acting was the most commonly received opioid (69.5% of injured workers). 
Ten percent of injured workers who received opioids also received a benzodiazepine, and all 
received an opioid within 30 days of that benzodiazepine.  
Conclusion  Prescription opioid dispensing to injured workers in Tennessee is high with one in 
three workers receiving opioids within six months of injury, and is prevalent across demographic 
categories. Prescribers for this population appear to be following guidelines, at least in the first 
six months after injury, with mean and standard deviation dose and days’ supply within 
recommended limits.  
Background 
 Opioids are a powerful treatment for providing relief from acute pain but can cause 
serious health problems when taken non-medically, not as prescribed, chronically, at high doses, 
or in combination with other drugs or alcohol (Eriksen, Sjogren, Bruera, Ekholm, & Rasmussen, 
2006). Improper prescription opioid use is associated with overdose, drug dependence, road 
traffic crashes, increased family stress, and heroin use (Kolar, Brown, Haertzen, & Michaelson, 
1994; Orriols, Delorme, Gadegbeku, Tricotel, Contrand et al., 2010; Palamar, Shearston, 
Dawson, Mateu-Gelabert, & Ompad, 2016; Trang, Al-Hasani, Salvemini, Salter, Gutstein et al., 
2015). Tennessee (TN) is among the hardest-hit states in the current prescription opioid epidemic 
and has the third highest prescribing rate (107.5 prescriptions per 100 persons in 2016) and the 
fifth highest prescribing rate of high dosage (≥90 daily MMEs) opioids (9.8 prescriptions per 100 
persons in 2016) (Centers for Disease Control and Prevention, 2014, 2017). Injured workers are 
a special population with regard to opioid use because of the need to balance pain relief with 
rehabilitation (Harris et al., 2005; Newton-John & McDonald, 2012), but no studies have 
reported on opioid use by this population in TN.  
One review of ten studies estimated that 31.8% of Workers’ Compensation (WC) 
claimants worldwide receive an opioid prescription during their claim, but prevalence varied 
widely by country and by state in the U.S. (Dembe et al., 2012). Research on the prevalence of 
opioid use by claimants using WC records has yielded lowest estimates in Illinois (6.6% within 
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90 days of injury), intermediate levels in Ohio (19.2% within 2 years) and Michigan (27% during 
course of treatment), and highest in Washington State (42% within one year) and Louisiana 
(46.4% within one year) (Dembe et al., 2012; Franklin, Rahman, Turner, Daniell, & Fulton-
Kehoe, 2009; Lavin et al., 2014; J. A. White, Tao, Artuso, Bilinski, Rademacher et al., 2014; J. 
A. White, Tao, Talreja, Tower, & Bernacki, 2012). Other studies have presented data from 
prescription drug monitoring programs and other government registries that are stratified by 
payment source, including WC, but to my knowledge, no study has used a prescription drug 
monitoring program to measure opioid use in injured workers accounting for all payment types 
(Kraut, Raymond, Ekuma, & Shafer, 2016). In prior studies, middle age, daily tobacco use, 
fractures and dislocation injuries, and back pain were associated with receiving an opioid, while 
associations with sex were mixed (Berecki-Gisolf, Collie, & McClure, 2014; Gross et al., 2009; 
Pensa, Galusha, & Cantley, 2017; Stover et al., 2006).  
Observed prescribing patterns for injured workers may  not follow prescribing guidelines, 
with opioids being prescribed for longer and at higher doses than is recommended (Cifuentes et 
al., 2010). In injured workers, opioid use is associated with increased medical and claim costs, 
delayed return to work, absenteeism, lost productivity, and progression to long-term disability 
(Kidner, Mayer, & Gatchel, 2009; Lavin et al., 2014; Rice, Kirson, Shei, Cummings, Bodnar et 
al., 2014). Adverse outcomes are more likely when opioids are received early after injury, in the 
presence of benzodiazepines, in long-acting formulas, and in high doses (Cifuentes et al., 2010; 
Franklin et al., 2009; Lavin et al., 2014). Visiting multiple prescribers and dispensers (doctor 
shopping) has also recently arisen as a key indicator for opioid misuse but few studies have 
evaluated doctor shopping as an adverse outcome in injured workers (Baumblatt, Wiedeman, 
Dunn, Schaffner, Paulozzi et al., 2014).  
Many studies from other states underestimate opioid use by measuring it through claims 
records alone and missing prescriptions that are paid for with other insurance, cash, Medicare, or 
Medicaid, and differences in patterns of use by geographic region and population characteristics 
limits the extent to which other findings can be applied to TN. TN is notable in being both 
amongst the hardest-hit states in the opioid epidemic (Centers for Disease Control and 
Prevention, 2016) and, to my knowledge, the first to link WC records to a prescription drug 
monitoring program. A retrospective cohort study was conducted among workers with an injury 
reported to the TN Bureau of WC in 2013-2015 to evaluate 1) the prevalence of filling an opioid 
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prescription after injury by year; 2) demographics and injury characteristics associated with 
opioid use in the first six months after injury; and 3) characteristics of opioid use after injury, 
including high-risk opioid prescribing patterns with the following research questions and 
hypotheses: 
 
RQ 2.1: What is the percentage of injured workers who receive opioids within one week, one 
month, and six months of injury from 2013 through 2015? 
Hypothesis: Tennessee falls in the upper range of states for opioid use by injured workers 
with the percentage receiving an opioid use after injury of >20% within one week, >25% 
within one month, and >30% within six months.  
RQ 2.2: Do injured workers who received opioids in the six months after injury differ by sex, 
age, residence area, or injury type compared to the injured workers who did not receive opioids? 
Hypothesis: Men, people of middle age groups, people living in east Tennessee, and 
people with more traumatic injuries have higher prevalence of receiving opioids (PR>1). 
Sex and age interact so that middle aged women have greater prevalence ratio than other 
sex and age groups of receiving opioids (PR of the interaction >1), and age and injury 
type interact so that older people with more traumatic injuries have higher prevalence 
ratio of receiving opioids (PR of the interaction>1) than people with less traumatic 
injuries.  
RQ 2.3: Among injured workers with one or more opioid prescriptions in the first six months 
after injury, what is the percentage who experienced any of five key high-risk patterns of opioid 
use compared to not experiencing that pattern: receiving greater than 80 mean daily morphine 
milligram equivalents (MMEs), receiving greater than 100 mean daily MMEs, combined opioid 
and benzodiazepine use, receiving a long-acting opioid, and having a multiple provider episode 
from 2013 through 2015? 
Hypothesis: Among injured workers who received opioids, the percentage receiving 
greater than 80 mean daily MMEs, combined opioid and benzodiazepine use, and a long-
acting opioid are high (30%) while the proportion receiving greater than 100 mean daily 
MMEs is lower but still high (20%) and the proportions with a multiple provider episode 
is low but still present (10%). 
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Methods 
Data sources. 
Data from 2013-2015 WC records and 2013-2016 Controlled Substances Monitoring 
Database (CSMD) was used in these studies. In TN, it is required by law for businesses with five 
or more employees and all construction and coal mining businesses to carry WC insurance 
(T.C.A. § 50-6-101 et seq., 2010). WC records were supplied by the Employer’s First Report of 
Illness or Injury form, which is compliant with reporting requirements of the Occupational 
Safety and Health Administration and which WC requires employers to submit within 15 days 
for each illness or injury occurring at their workplace (Occupational Safety and Health 
Administration; Tennessee Bureau of Workers’ Compensation). Years 2013-2015 of the data 
were provided to the TN Department of Health from the TN Department of Labor as part of an 
ongoing collaboration, and are representative of injured workers in Tennessee.  
The CSMD includes data about every controlled substance that is legally dispensed in 
outpatient settings in TN. Data entry by dispensers is mandatory in most cases (excluding 
inpatient settings, drugs dispensed by veterinarians with ≤5 days’ supply, drug samples and 
drugs given by a facility with ≤48 hours’ supply, drug samples for schedule IV and V substances 
with ≤72 hours’ supply, and narcotic treatment programs registered with and required to keep 
records by the Drug Enforcement Agency.) ("Prescription Safety Act of 2012," 2012), and the 
database has been funded since 2012 (T.C.A. § 53-10-3, 2012). This study uses data from the last 
quarter of 2012 through mid-2016, including prescriptions for each injured worker from two 
months before their date of injury through six months after injury.   
Workers who reported an injury to the TN Bureau of WC from 2013 through 2015 were 
matched to their prescription history in the CSMD on name and date of birth. Names were 
cleaned to standardize formats, remove prefixes and suffixes, and separate multiple names into 
separate fields (maximum four). Dates were cleaned to remove improbable dates of birth and 
prescriptions where the date of birth fell on or after the date that the prescription was filled. 
Linkage between WC records and the CSMD was done deterministically, where two records 
were considered a match if they had a link between any of the four first name fields, a link 
between any of the four last name fields, and the same date of birth. This study was approved by 
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the Institutional Review Boards at the Tennessee Department of Health and University of 
Hawaii.  
Study population. 
The main study population was Tennessee residents age 15-99 years old who reported 
only one injury to TN WC 2013-2015. Workers were excluded if they were missing date of birth 
or age <15 or ≥100 years at the time of injury, missing sex, had no physical injury, or resided out 
of state (Figure 1). Workers who were missing name or date of birth on their report of injury 
form were excluded to prevent error in matching to prescription records Workers with missing 
sex were excluded as sex was a key variable under study. Workers residing out of state were 
excluded to prevent underestimation of prescriptions received out of state. People whose nature 
of injury code indicated no physical injury were also excluded to limit opioids that were not 
prescribed for an injury. Workers who reported more than one injury were excluded from 
analyses to avoid confounding by previous injuries, but their demographics were presented for 
comparison to people who had only one injury.  
Inclusion criteria for opioids were schedule II-IV drugs. Prescriptions from Veterans 
Affairs pharmacies (indicated by drug enforcement agency number for the pharmacy, n=548) 
were excluded to focus on a non-military population and prescriptions from veterinarians 
(indicated by prescriber’s educational degree, n=8) were excluded to remove opioids given to 
animals. Additionally, prescriptions for opioids indicated for medication assisted therapy (MAT, 
including all burprenorphine except butrans and belbuca, n=3746) were excluded to focus on 
opioids given for pain. Prescription exclusions only excluded prescriptions for eligible persons: 
no person was excluded from the study population based on these criteria.  
Demographics and injury characteristics.  
Age at the time of injury, sex, region of residence, marital status, type of injury, and part 
of body injured were collected from WC records and were selected based on availability, 
completeness of data, and previous literature identifying risk factors for opioid use including 
middle age, fractures and dislocation injuries, and back pain. Associations of opioid use with sex 
are mixed in previous literature on injured workers, with some studies showing more opioid use 
by females and some showing more by males (Berecki-Gisolf et al., 2014; Gross et al., 2009; 
Stover et al., 2006). The most frequently occurring types of injury were selected and remaining 
types of injury were grouped into an “other” category for analysis. When overlapping confidence 
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intervals were observed among many injury groups in regression analyses, injury type was 
reclassified into strains, sprains, and tears, fractures, and other. Geographical region of residence 
was classified into east, middle, and west Tennessee based on geocoded zip code. East 
Tennessee covered Knoxville/Knox County, East Tennessee, Northeast Tennessee, Sullivan, 
Southeast, and Chattanooga-Hamilton regions. Middle Tennessee comprised South Central, 
Upper-Cumberland, Mid-Cumberland, and Nashville-Davidson regions. West Tennessee 
included Northwest, West Tennessee, Memphis/Shelby County, and Jackson/Madison County 
regions. Region of residence was also classified into urban and rural. The urban category 
included the counties with the 6 largest cities in Tennessee (urban region population density 
range 176.4 – 1,243.3 people per square mile) (Tennessee Department of Health, Local and 
regional health departments). To better describe the sample, the distribution of industry (from 
North American Industry Classification System codes) was also described.  
Prescription outcome measures.  
The primary outcome was filling a prescription for an opioid (hereafter referred to as 
receiving an opioid) within six months of injury. Secondary outcomes were receiving an opioid 
within one week and one month of injury, type of payment, and opioid prescribing patterns 
including dose in daily morphine milligram equivalents (MMEs), days’ supply, type of opioid,  
and four high-risk opioid patterns: 1) receiving >100 daily MMEs, 2) receiving a long-acting 
opioid at any point within 6 months of injury, 3) receiving an opioid within 30 days of a 
benzodiazepine, and 4) having a multiple provider episode, defined here as visiting ≥3 
prescribers and ≥3 dispensers in the 180 days after injury (Dowell, Haegerich, & Chou, 2016; 
Kowalski-McGraw, Green-McKenzie, Pandalai, & Schulte, 2017a).  
Statistical analysis. 
Frequencies, proportions, means, and standard deviations (SD) were used to describe the 
population. Means, standard deviations and proportions were used to describe the distribution of 
measures of opioid use in the six months after injury and other demographic and clinical 
characteristics within the study sample. 
To identify associations between demographics and injury characteristics for our primary 
outcome of receiving an opioid within 6 months of injury, Poisson regression with a log link 
function was used to compute unadjusted and adjusted prevalence ratios (PRs) with 95% 
confidence intervals (CIs). Poisson regression was chosen because the model failed to converge 
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when log-binomial regression was used. The covariates used for adjusted models were 
determined a priori and were age, sex, type of injury, part of body injured, region of residence, 
and opioid use before injury. Following reports that younger males and older females are groups 
of concern for opioid use in the overall U.S. population (Krueger, 2017; Substance Abuse and 
Mental Health Services Administration, Opioid use in the older adult population, 2017), two 
factor interactions were tested for between age and sex, age and prior opioid use, and sex and 
prior opioid use.  Sensitivity analyses additionally adjusting for marital status and excluding 
workers with severe injury types were conducted. Respondents with missing or unknown values 
for the selected variables were excluded from the multivariable analysis. 
Prescribing patterns were described with mean, standard deviation, and sample 
percentages. Trends by year in the percentage of injured workers receiving opioids and, among 
those receiving opioids, the percentage receiving a high risk pattern, were tested for with the 
Cochran-Armitage test. Although our analysis focuses on opioid analgesic use, the proportion of 
workers given opioids for MAT and benzodiazepines in the two months before and six months 
after injury, and the types of benzodiazepines that were prescribed were also reported. All 
statistical tests were two-sided with a statistical significance level of p < 0.05 and were 
conducted using SAS v 9.4 (SAS Institute, Cary, NC).  
Results 
Demographics and receipt of an opioid after injury. 
Of 202,380 workers who reported injuries to TN WC 2013-2015, 188,608 reported only 
one injury (93.2%) and 172,256 (85.1%) were eligible for this study (Figure 2.1).  The study 
population was predominantly middle aged (mean 42.1 years ± 13.39 years SD), male (55.3%), 
from rural areas of residence (61.6%), from middle TN (42.6%) and injured with strains, sprains, 
or tears (35.4%) (Table 2.1). In 2015, 21.7% of injured workers received an opioid within 1 
week of injury, 28.4% received an opioid within 1 month of injury, and 31.8% received an 
opioid within 6 months of injury (Figure 2.2). Among workers who received opioids within 6 
months of injury in 2015, 80% (n=14,544) were opioid-free at the time of injury (Appendix 2, 
Table S2.1). 
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Figure 2.1: Study population flowchart. 
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Table 2.1: Characteristics of injured workers who reported one injury compared to those who reported 2 or 
more injuries to TN Workers’ Compensation 2013-2015 (N=202,380) 
Characteristic   
Injured workers with one 
injury (N=172,256) 
Injured workers with ≥ 2 
injuries (N=30,124) 
Age in years, mean (SD)  40.3 (13.74) 40.7 (13.00) 
  n % n % 
Age, years     
15 - 34 66430  38.6 10857 36.0 
35 - 54 74871  43.5 14160 47.0 
55 - 99 30955  18.0 5107 17.0 
Sex      
   Female 76994 44.7 12716 42.2 
   Male 95262 55.3 17408 57.8 
Marital Status      
  Single 3719 2.2 599 2.0 
  Married 45424 26.4 8157 27.1 
  Widowed, separated, or divorced 42232 24.5 7318 24.3 
  Unknown or missing  80881 47.0 14050 46.6 
Region of residence     
   Rural 106185 61.6 18634 61.9 
   Urban 66071 38.4 11490 38.1 
Geographical area     
   East 61964 36.0 10098 33.5 
   Middle 73289 42.6 13812 45.9 
   West 37003 21.5 6214 20.6 
Definitions: TN=Tennessee; SD=standard deviation 
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Compared to injured workers who did not receive opioids within 6 months of injury, 
those who received opioids were older (mean 42.1 ± 13.39 SD vs mean 39.5 ± 13.84 SD) and 
more likely to be from a rural region (63.5% vs 60.7%). Women had slightly less opioid use than 
men (54.7% vs. 56.5%). Workers of middle age groups had overlapping prevalence ratio 
confidence intervals of receiving an opioid (data not shown), so age categories were collapsed 
into 15-34 years, 35-54 years, and 55-99 years and the association of age with opioid use was 
PR=1.3 (95% CI 1.28-1.33) for age 35-54 vs. 15-34 and PR=1.3 (95% CI 1.30-1.37) for age 55-
99 vs 15-34 (Table 2.2). Industry had 56% missing values but, among those who had reported 
data, workers in wholesale and retail trades were more likely than those in other jobs to receive 
an opioid (Appendix 2, Table S2.2).  
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Table 2.2: Estimated associations (prevalence ratios [PRs] and 95% confidence intervals [CIs]  of 
demographic characteristics and type of injury with receiving an opioid analgesic within 6 months of injury 
in workers who reported one injury to TN Workers’ Compensation 2013-2015 (N=172,256): Results from 
Poisson regression analyses. 
Characteristic 
Opioid prescription filled within 6 months of 
injury 
Unadjusted PR 
(95% CI) No (n=114,974)  Yes (n=57,282)  
Age, mean (SD) 
39.5 (13.84)  42.1 (13.39)  
Age, years n (%) n (%)  
15 - 34 47892 (41.7) 18538 (32.4) 1.0 (ref) 
35 - 54 47652 (41.4) 27219 (47.5) 1.3 (1.28-1.33) 
55 - 99 19430 (16.9) 11525 (20.1) 1.3 (1.30-1.37) 
Sex    
Female 52070 (45.3) 24924 (43.5) 1.0 (ref) 
Male 62904 (54.7) 32358 (56.5) 1.05 (1.03-1.07) 
Type of injury    
Other 73383 (63.8) 30109 (52.6) 1.0 (ref) 
Strain, sprain, or tear 38996 (33.9) 21988 (38.4) 1.2 (1.22-1.26) 
Fracture 2595 (2.3) 5185 (9.0) 2.3 (2.22-2.36) 
Part of body     
Other 67374 (58.6) 32180 (56.2) 1.0 (ref) 
Finger(s) 12773 (11.1) 5498 (9.6) 1.0 (0.97-1.03) 
Lower back 10660 (9.3) 7005 (12.2) 1.2 (1.16-1.23) 
   Multiple body parts 7847 (6.8) 4680 (8.2) 1.2 (1.14-1.22) 
Hand 8705 ((7.6) 3466 (6.0) 0.95 (0.92-0.99) 
Knee 7615 (6.6) 4453 (7.8) 1.1 (1.10-1.18) 
Region    
Rural 69827 (60.7) 36358 (63.5) 1.0 (ref) 
Urban 45147 (39.3) 20924 (36.5) 0.9 (0.91-0.94) 
Geographical area    
   East 41538 (36.1) 20426 (35.7) 1.0 (ref) 
   Middle 49784 (43.3) 23505 (41.0) 0.97 (0.95-0.99) 
   West 23652 (20.6) 13351 (23.3) 1.1 (1.07-1.12) 
Prior opioid use 5568 (4.8) 12052 (21.0) 2.3 (2.29-2.39) 
Definitions: TN=Tennessee; PR=prevalence ratio; SD=standard deviation 
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Having a fracture (PR=2.3, 95% CI 2.22-2.36 compared to having another injury) and 
having a record for opioid use prior to injury (PR=2.3, 95% CI 2.29-2.39) were most strongly 
associated with receiving an opioid in the 6 months after injury. Having a strain, sprain, or tear 
(PR=1.2, 95% CI 1.22-1.26) was also associated with receiving an opioid in the 6 months after 
injury, but associations differed by part of body with lower back strains, sprains, or tears being 
associated with more opioid use than strains, sprains, and tears in other parts of the body 
(Appendix 2, Table S2.3). Fractures were more likely to receive an opioid if they had a finger 
fracture and less likely if they had a wrist fracture.  
Sensitivity analyses were conducted by adjusting for marital status (where data not 
missing) and excluding people with extreme injuries including crushing (n=1819), amputation 
(n=382), rupture (n=190), myocardial infarction (n=144), severance (n=109), AIDS (n=33), 
cancer (n=18), hepatitis C (n=12), and black lung (n=2). After adjustment, finger injuries and 
residence in Middle TN were no longer associated with opioid use but other associations were 
similar. No interactions were found between age and sex, age and prior opioid use, or sex and 
prior opioid use. There was a small but significant decrease in the percentage of injured workers 
receiving opioids by year (Appendix 2, Table S2.1), but controlling for year in the multivariable 
model did not alter associations between other variables and opioid use.  
Patterns of opioid use. 
Among workers who received opioids, the maximum doses (mean 42.8 ± 39.26 SD) and 
maximum days’ supply (mean 9.4 ± 9.81 SD) were moderate. Only 5.0% (n=2866) received a 
prescription for >100 daily MMEs. The numbers of prescribers and dispensers visited were also 
low, with 80.2% of injured workers (n=38346) visiting only one prescriber and one dispenser. 
Two percent (n=1185) visited ≥3 prescribers and ≥3 dispensers and qualified as having a 
multiple provider episode. Only 39 injured workers who had one injury visited ≥5 prescribers 
and ≥5 dispensers for opioids in the six months after injury. Most workers received Hydrocodone 
short-acting (SA) (69.5%), Oxycodone SA (23.0%) and/or Tramadol SA (23.8%) (nonexclusive 
categories). The prevalence of receiving a long-acting opioid was 2.5% and receiving an opioid 
within 30 days of receiving a benzodiazepine was 9.5% (Table 2.3). 
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Table 2.3: Description of opioid analgesic use in the 6 months after injury by workers who reported one 
injury to TN Workers’ Compensation 2013-2015 (n=57,282)^* 
 Mean (SD) Median (IQR) 
Maximum received daily MME 42.8 (39.26) 31.3 (21.43-50.00) 
Maximum received days’ supply 9.4 (9.81) 5.0 (3.00-10.00) 
Number of prescribers visited 1.4 (0.76) 1 (1.00-2.00) 
Number of dispensers visited 1.2 (0.52) 1 (1.00-1.00) 
Most frequently received types of opioid* n  %  
   Hydrocodone SA 39813 69.5 
   Oxycodone SA 13171 23.0 
   Tramadol SA 13647 23.8 
   Codeine 2084 3.6 
   Morphine LA 472 0.8 
Type of payment*   
   Commercial Insurance 37283 65.1 
   Workers’ Compensation 11567 20.2 
   Cash 10599 18.5 
   Medicaid 3966 6.9 
   Medicare 1152 2.0 
   Military 10 0.02 
   Indian Nations 1 0.0 
High-risk opioid prescribing pattern experienced   
   Opioid received within 30 days of a benzodiazepine 5451 9.5 
  >100 mean daily MMEs 2866 5.0 
   Long-acting opioid 1437 2.5 
   Multiple provider episode** 1185 2.1 
Received a benzodiazepine in the 6 months after injury 5785 10.1 
Most frequently received types of benzodiazepine*   
   Alprazolam 2683 4.7 
   Diazepam 1415 2.5 
   Clonazepam 1025 1.8 
   Lorazepam 652 1.1 
   Temazepam 221 0.4 
Definitions: TN=Tennessee; SD=standard deviation; IQR=interquartile range; MME=morphine milligram 
equivalents; SA=short acting; LA=long acting 
^ Table is limited to injured workers who received an opioid within 6 months of injury 
* Categories are non-exclusive, injured workers may appear in more than one category 
** Visiting ≥3 prescribers and ≥3 providers in the 6 months after injury 
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Prescription-level changes by year were assessed in the top ten prescribed opioids. There 
was no change by year in the top 7 prescribed opioids, but the 8
th
, 9
th
, and 10
th
 most prescribed 
opioids in 2013 (Meperidine, Hydromorphone SA, and Methadone, all 0.4% prevalence) 
changed in 2015 (Hydromorphone SA 0.5%, Fentanyl LA 0.4%, and Meperidine 0.3% of 
prescriptions). Changes in high risk patterns by year were tested for and significant decreases 
were found for receiving >100 mean daily MME (5.6% in 2013 vs. 5.0% in 2015, p<0.01), 
receiving a long-acting opioid (2.8% in 2013 vs. 2.3% in 2015, p<0.01), and having a multiple 
provider episode (2.4% in 2013 vs. 1.9% in 2015, p<0.01). Receiving an opioid within 30 days 
of a benzodiazepine had no significant change.  
Most workers used a private, commercial insurance to pay for opioids (65.1%) and one-
fifth (n=11,567) used WC to pay for a prescription (Table 3). Five percent (n=3064) used both 
commercial insurance and WC, 1.9% (n=1106) used both cash and WC, and 0.5% (n=272) used 
both Medicaid and WC to pay for opioids. Very few prescriptions (n=867, 1.5%) had unspecified 
payment type. 
Few (n=759) injured workers in this study population received buprenorphine for MAT 
(0.4% of the total 172,256). All had a record for receiving MAT prior to injury, with 198 
(26.1%) also receiving an opioid analgesic after injury but no new courses of MAT were started 
within the six months after injury. Because of a short follow up time, later trends in MAT use 
could not be ascertained.  
Benzodiazepine use was more widespread, with 5.6% (n=9,575) of the total sample and 
10.1% (n=5,785) of workers who received opioids filling a prescription for this class of drug. All 
5785 opioid users that received a benzodiazepine after injury also had a record for filling a 
benzodiazepine before injury, and all received an opioid within 30 days of a benzodiazepine. The 
most frequently used benzodiazepine was Alprazolam (n=2683 injured workers, 4.7%) (Table 
2.3). Benzodiazepine use did not show a significant trend in changing over time. Type of 
benzodiazepine was not described by trends over time, dose, or days’ supply due to small sample 
size.   
Discussion 
 This population-based study of injured workers in Tennessee found widespread opioid 
use that generally fell within recommended guidelines. Almost one fifth of people who reported 
only one injury from 2013-2015 received an opioid within a week of injury, one fourth received 
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an opioid within one month of injury, and one third received an opioid within six months of 
injury.  
Among people who received opioids, mean dose and days’ supply were within 
prescribing guidelines. The Tennessee Chronic Pain Guidelines set an upper threshold of 120 
daily MME as the maximum dose that should be prescribed without referral to a pain specialist 
(Tennessee Department of Health, 2014), and 95% of injured workers in this study had their 
maximum dose fall below this threshold. Similarly, 85% of injured workers received no 
prescription over the maximum 30 days’ supply allowed by Tennessee state law for schedule II 
and III controlled substances  ("Prescription Requirements," 2013). The numbers of prescribers 
and dispensers visited were low (80.2% visited only one prescriber and only one dispenser), as 
was the prevalence of high-risk opioid use patterns such as receiving a long-acting opioid and 
having an opioid within 30 days of a benzodiazepine. A low proportion of the total sample 
received benzodiazepines. This proportion was doubled in people who received opioids, 
demonstrating a potential area for intervention.  
The prevalence of opioid use observed in this study is consistent with a previous review 
of worldwide Workers’ Compensation claimants from 2000-2010 that found an opioid use 
prevalence of 31.8% (Dembe et al., 2012). Compared to other states, the prevalence of opioid use 
after injury in Tennessee appears to be higher than Ohio (19.2% of Workers’ Compensation 
claimants receive an opioid during their claim) and may be similar to the 42% prevalence 
observed in Washington or 46.4% prevalence observed in Louisiana if this study had the same 1-
year follow up time like these studies (Dembe et al., 2012; Franklin et al., 2009; Lavin et al., 
2014). However, these studies used WC records to measure opioid use and are likely 
underestimates due to their confinement to a single payer source. The estimates presented in this 
paper are expected to be more accurate due to measuring opioids received through all payer 
sources.  
This study found similar associations between demographic and injury variables and 
opioid use as prior studies. Similar to the results in this study, a large study of U.S. WC 
claimants showed middle and older age groups were more likely than younger age groups to 
receive an opioid after injury (OR=2.6, 95% CI 1.81-3.87 for age >55 vs. <26) (Pensa et al., 
2017). Another previous study in Alberta WC claimants found that fractures and dislocations had 
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higher odds (OR=2.5, 95% CI 2.14-2.36) of receiving an opioid in a year after injury compared 
to back sprains (Gross et al., 2009).  
The prevalence of high-risk opioid patterns observed in this study is consistent with 
previous literature. In Ohio 2008-2009, mean MME during a WC claim was 57.5 and 10% of 
injured workers received ≥120 daily MMEs. In this study, 75% of injured workers 2013-2015 
received no more than 50 MMEs on all prescriptions, a decrease that may reflect a nationwide 
trend in decreasing MMEs over this time period (Dembe et al., 2012; Guy, Zhang, Bohm, Losby, 
Lewis et al., 2017). In Ottawa, WC claimants undergoing shoulder, knee, back, or carpal tunnel 
surgery received a comparatively lower mean dose of 11.25 daily MMEs (Kraut et al., 2016). In 
a nationwide study of WC claimants with low back pain, 9.4% received a long-acting opioid 
within 2 years of injury (Cifuentes et al., 2010). No research measuring multiple provider 
episodes in WC claimants or injured workers was found, and the results in this study indicate 
that it may not be a substantial problem. In the overall TN population in 2016, the rate of visiting 
≥5 prescribers and ≥5 dispensers in six months was 49.96 per 100,000 persons (Prescription 
Drug Overdose Program 2018 Report: Understanding and responding to the opioid epidemic 
inTN using Morbidity, Mortality, and Prescription Data, January, 2018) Using the same metric 
in this population of workers who reported only one injury, the rate was 22.64 per 100,000 
persons. 
This study casts light on benzodiazepine use by injured workers. Of the 9,575 people who 
received a benzodiazepine in the two months before injury in the total sample, 60.4% (n=5,785) 
received an opioid after injury while continuing their benzodiazepine use and 39.6% did not 
receive an opioid. This is a higher proportion that than observed in a study of Workers’ 
Compensation claims in Louisiana 1999-2002 (4.9%) and may reflect an increased use of 
benzodiazepines in recent years or in TN. In Louisiana, claimants with benzodiazepine use 
demonstrated benzodiazepine dose escalation over 3 years post injury, and claims with 
benzodiazepines and short-acting opioids cost triple those of short-acting opioids alone (Lavin et 
al., 2014).   
Tennessee has implemented a number of legislative policies intended to combat the 
opioid epidemic. In 2012, Tennessee mandated participation in a prescription drug monitoring 
program (the CSMD, a key data source for this study) for prescribers and dispensers of 
controlled substances. This was followed by the release of updated Chronic Pain Guidelines in 
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2014, and a tightening of regulations on pain clinics and a repeal in 2015 of legislation known as 
“The Pain Patient’s Bill of Rights” that virtually guaranteed access to opioids (Tennessee 
Department of Health, 2015).  The decreases observed in the prevalence of opioid use in 2013-
2015 may be early effects of these interventions and underscore the need for sustained attention 
toward controlling opioid prescribing. That observed prescribing patterns parallel recent 
prescribing guidelines underscores the success of involving clinicians and pharmacists as 
partners with regulators. The results of this study have high applicability to TN but may not be 
generalizable to other states. 
Limitations. 
This study controlled for type of injury reported to Workers’ Compensation, but could not 
account for other, unreported injuries or comorbidities that may influence opioid use, including 
education, filling prescriptions out-of-state, concomitant medication, years on the job, socio-
economic status, other alcohol, tobacco, and drug use, past drug-related hospitalizations, age at 
first opioid prescription, and criminal history. Particularly, this study could not control for mental 
health conditions that, especially depression and other drug use, are frequently associated with 
higher odds of both prescription opioid use and adverse effects from opioids (Hah, Sturgeon, 
Zocca, Sharifzadeh, & Mackey, 2017; Inacio, Hansen, Pratt, Graves, & Roughead, 2016; 
Kowalski-McGraw, Green-McKenzie, Pandalai, & Schulte, 2017b; Schoenfeld, Nwosu, Jiang, 
Yau, Chaudhary et al., 2017). Had these variables been available, they are expected to be key 
predictors of opioid use.  However, the same factors that make people with mental health 
diagnoses more likely to use opioids after injury also influence their likeliness to use opioids 
prior to injury, thus prior opioid use is expected to be a confounder in the association between 
mental health diagnoses and opioid use after injury.  Stratification would be a preferable strategy 
in this case to understand the effects of both mental health diagnoses and prior opioid use.  
Mental health diagnoses would also be expected to decrease the association between sex and 
opioid use in the multivariable model, if the association were not already null in this study. 
Similarly, this study was not able to assess the role of race in opioid use. Estimates of opioid 
use may be confounded by race and ethnicity, which are not collected by the CSMD or Workers’ 
Compensation databases. Studies in other states show that Whites tend to be prescribed opioids 
more frequently (Pensa et al., 2017) but non-Whites are more likely to be recipients of Workers’ 
Compensation (Atlas, Tosteson, Hanscom, Blood, Pransky et al., 2007) In 2016, Tennessee’s 
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population was 74.2% White alone, 17.1% Black or African American alone, and 5.2% Hispanic 
or Latino (United States Census Bureau, 2016). As the racial makeup of the claimant sample is 
unknown, it is unknown how race may have affected this study’s estimates. 
This study likely underestimates the total burden of opioid use in injured workers as 
workers with more than one injury were not included. There is also evidence that, although 
reporting of workplace injuries is mandated by state law, many workplace injuries go unreported 
(Committee on Education and Labor, 2008).  Workers with more injuries may have more 
contacts with medical care and residual pain or prescriptions from previous injuries resulting in 
more overall opioid use (Kowalski-McGraw et al., 2017b). However, if injuries are not reported 
because of their lack of severity then opioid use would not be expected.  
Drug diversion is a well-known phenomenon for controlled substances that may bias 
estimates of use that are based on legally obtained drugs. This study only has data on 
prescription opioids purchased from dispensers. Similarly, this study measures only prescriptions 
that were filled, with no way to measure whether those prescriptions were consumed. However, 
in using the CSMD to identify and measure opioid use this study will substantially improve the 
accuracy of estimates made with WC records alone by including opioids paid for with cash and 
other forms of payment, regardless of claim approval.  
Conclusions.  
In conclusion, opioid use by injured workers in TN is widespread but generally within 
prescribing guidelines. This study is the first in TN to describe opioid use by injured workers, 
and among the first nationally to use a prescription drug monitoring program linked to WC 
records for this purpose, but more research is needed into what happens after opioids are initiated 
in injured workers. This work is built upon in the following two studies evaluating long-term 
opioid use and clinical events related to drug use after injury.  
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Chapter 3 
 Patterns of prescription opioid use associated with nonfatal opioid overdose: A case-
control study using linked statewide databases in Tennessee. 
Abstract 
Background  Opioid overdoses are now the leading cause of accidental death in Tennessee 
(TN). Although prescribing rates have begun to decrease since the enactment of prescribing 
controls intended to constrain the opioid epidemic, the burgeoning rate of overdoses shows no 
sign of decreasing. High opioid use by injured workers in TN raises concerns about overdose in 
this population, but this topic has not been studied before in TN.  
Objective  We conducted a nested case-control study to evaluate the frequency of nonfatal 
opioid overdose after injury and the prescription opioid use patterns associated with this outcome 
in workers who reported one injury to TN Workers’ Compensation in 2013.   
Methods Injured workers were linked to their prescription history in TN’s prescription drug 
monitoring program and hospitalization and emergency department records in TN’s Hospital 
Discharge Data Set and followed for three years after injury. Cases were workers who had a 
nonfatal opioid-related hospitalization or emergency department visit after injury. Controls were 
workers who did not have a nonfatal overdose during follow up and did not die before their 
matched case’s date of overdose. Each case was matched to five controls on sex and age ± one 
year. Overdose characteristics were described and conditional logistic regression was used to 
evaluate risk factors. 
Results  From the cohort of 29,972 workers injured in 2013, 101 cases and 505 controls were 
included in this study. Among cases, 72.3% (n=72) overdosed on prescription opioids, 10.9% 
(n=11) on heroin, 9.9% (n=10) on opium, and 7.0% (n=7) on both prescription opioids and 
heroin. Over a quarter (n=29, 28.7%) of cases had no record of receiving a prescription opioid 
analgesic in the six months before overdose. Cases were significantly more likely (p<0.05) than 
controls to have knee injuries (67.3% vs. 9.1%), cancer (6.9% vs. 1.4%), depression (19.8% vs. 
9.9%), a bipolar or psychotic disorder (9.9% vs. 2.4%), a positive Charlson comorbidity score 
(25.7% vs. 18.6% for a score of 1 and 26.7% vs. 7.5% for a score of ≥2), and receipt of a 
benzodiazepine (31.7% vs. 10.3%) or muscle relaxant (5.9% vs. 1.6%). After adjusting for 
Charlson comorbidity score, the only opioid use pattern strongly associated with overdose was 
receiving a benzodiazepine within one month of injury (odds ratio [OR]=3.9, 95% CI 1.75-8.52) 
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while the maximum received dose of morphine milligram equivalents received within one month 
of injury was weakly associated (OR=1.03, 95% CI 1.01-1.05). After surviving a nonfatal 
overdose, over half of cases (57.4%, n=58) received another prescription opioid within six 
months, and ten cases (9.9%) had subsequent nonfatal and/or fatal overdoses.  
Conclusion  This study provides a detailed description of the clinical and prescribing 
characteristics of opioid overdose by injured workers and sheds light on the complex relationship 
between opioid prescribing and overdose as well as what happens after overdose. Although most 
cases overdosed on prescription opioids, cases tended to have no prescription history prior to 
overdose or have a prescription history but not have any records for prescriptions within a month 
of overdose. Charlson comorbidity score confounded associations between opioid use and 
overdose except for benzodiazepine use. 
Background 
Opioid overdoses have increased in Tennessee (TN) every year since 2009 and are now 
the leading cause of accidental death in the state. In 2016, the TN mortality rate due to opioid 
overdoses was 24.5 per 100,000 (Tennessee Department of Health, Data Dashboard). In 2014, 
the overall United States opioid overdose mortality rate was 14.7 per 100,000. In TN and 
nationally, overdose rates are highest among people who are working aged, or 15-64 years old 
(Centers for Disease Control and Prevention, 2015).  
In the general U.S. population, males, middle-aged adults, people living in rural areas, 
and Whites are more likely to fatally overdose on prescription painkillers than females, children, 
older adults, people living in urban areas, and Blacks or Hispanics (Rudd et al., 2016) . In a 2014 
study of the National Inpatient Sample, urban residents were more likely to have a nonfatal 
overdose than rural residents (Centers for Disease Control and Prevention, 2011; Mosher, Zhou, 
Thurman, Sarrazin, & Ohl, 2017). Workers tend to have different characteristics and behaviors 
from the general population, however, and there may be uncertainty in applying risk factors 
observed in other groups to them (Dembe et al., 2012). Among people who had an opioid-related 
death in Utah, WC claimants were more likely than people in the overall population to have less 
education, have depression or anxiety, and use tobacco, alcohol, or other drugs, but less likely to 
use medications recreationally (Cheng, Sauer, Johnson, Porucznik, & Hegmann, 2013) or to use 
an unprescribed opioid (Fulton-Kehoe, Garg, Turner, Bauer, Sullivan et al., 2013).  
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In recent years, studies have shifted to opioid prescribing as a risk factor for overdose, 
and high opioid use by injured workers in TN (Durand, Krishnaswami, Nechuta, Hurwitz, & 
McPheeters, 2018) raises concerns. Dosage is one of the most well explored risk factors for 
overdose, with 100 mean daily morphine milligram equivalents (MMEs) commonly used as a 
threshold in prescribing guidelines (Tennessee Department of Health, 2014). Compared to 
receiving less than 20 mean daily MMEs, 100 mean daily MMEs has been linked to higher risk 
of overdose in the national Veteran Administration population (risk ratio [RR] = 4.1, 95% CI 
2.6-6.5) (Zedler, Zie, Wang, Joyce, Vick et al., 2014) and in the general TN population (odds 
ratio [OR]=11.2, 95% CI 8.3-15.1) (Baumblatt et al., 2014). However, doses as low as 50 MMEs 
per day have been linked to increased odds of overdose in Colorado Medicaid beneficiaries 
(OR=1.99, 95% CI 1.51-2.61 compared to receiving less than 50 MMEs per day) 
(Dilokthornsakul, Moore, Campbell, Lodge, Traugott et al., 2016) and researchers point out that 
no dose is “safe” (Coyle, Pratt, Ocran-Appiah, Secora, Kornegay et al., 2017). 
While dosage appears to be an important factor, it does not entirely explain the 
relationship between opioid use and overdose. Other high-risk patterns are emerging in the 
literature, including visiting multiple prescribers and dispensers (also called multiple provider 
episodes or doctor shopping), using more potent opioids, and using benzodiazepines combined 
with opioids (Bohnert, Logan, Ganoczy, & Dowell, 2016; Dilokthornsakul et al., 2016) A study 
of the overall state population by the TN Department of Health in 2014 found greatly increased 
odds of fatal overdose from visiting 4 or more prescribers (OR=6.5, 95% CI 4.4-8.3) and 4 or 
more pharmacies (OR=6.0, 95% CI 4.4-8.3) even after dosage was controlled for (Baumblatt et 
al., 2014). 
In Washington WC claimants, more potent schedule II opioids and long-acting opioids 
appear more frequently in overdose cases than less potent schedule II and IV opioids and shorter-
acting opioids (Franklin, Mai, Wickizer, Turner, Fulton-Kehoe et al., 2005; Fulton-Kehoe et al., 
2013). In the Veterans Health Administration population, long-acting opioids are associated with 
greater risk of overdose (hazard ratio [HR] = 2.3), especially when given before trying other 
therapies (HR = 5.3) (Miller, Barber, Leatherman, Fonda, Hermos et al., 2015). The Veterans 
Administration population also shows an increased risk of overdose from concurrent receipt of 
opioids and benzodiazepines (HR = 3.9), which increases as benzodiazepine dosage increases 
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(Park, Lin, Hosanagar, Kogowski, Paige et al., 2016; Park, Saitz, Ganoczy, Ilgen, & Bohnert, 
2015). 
These studies’ findings suggest that changes to opioid prescribing may be an opportunity 
to lower opioid-related overdoses in injured workers. Additionally, a recent qualitative study 
demonstrated optimistic bias, or an individual’s belief that their risk of a particular outcome is 
lower than others in a similar risk group, amongst prescription opioid users (Frank, Mateu-
Gelabert, Guarino, Bennett, Wendel et al., 2015), highlighting the importance of controlling 
opioid access at the prescriber and dispenser levels rather than depending on patients to self-
regulate. A recent review has highlighted the connection between prescribing and overdose and 
called for better characterization of populations taking opioids in order to describe risk factors in 
greater detail (Park et al., 2016). 
Several demographic characteristics and high-risk prescribing patterns have been linked 
to increased risk of overdose in WC claimants, Medicaid beneficiaries, and the Veterans’ 
Administration population in other states, but research is scarce on the rate of overdose and other 
opioid use risk factors for overdose in injured workers and no research has been published for 
this population in TN. Previous studies may also have had insufficient follow up time: one study 
on WC claimants found that two-thirds of opioid poisonings in this population occurred over a 
year after the claim was opened (Fulton-Kehoe et al., 2013). This study will follow injured 
workers for three years and triangulate three large data sources to quantify the frequency and 
timing of opioid overdoses in injured workers, describe the relationship between prescribing and 
overdose, and identify demographic and prescription risk factors for overdose, with the following 
research questions and hypotheses:  
RQ 3.1: How do the incidence rates of nonfatal opioid-involved overdose amongst injured 
workers compare to the incidence rates in the general population of Tennessee? 
Hypothesis: Opioid-involved overdoses are less common in injured workers than in the 
general population (incidence rate ratios <1). 
RQ 3.2: What are the associations of type of injury, early initiation of opioid therapy, prior 
history of opioid use, long-acting opioids, cash payment, combined opioid and benzodiazepine 
use, and multiple provider episodes with the odds of nonfatal overdose amongst injured workers 
with one or more opioid prescriptions? 
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Hypothesis: More traumatic injuries, early initiation of opioid therapy, prior history of 
opioid use, long-acting opioids, cash payment, combined opioid and benzodiazepine use, 
and multiple provider episodes are associated with nonfatal overdose (OR>1). 
RQ 3.3: Is mean daily morphine milligram equivalents (MME) a mediator in the associations 
between type of injury, early initiation of opioid therapy, prior history of opioid use, long-acting 
opioids, cash payment, combined opioid and benzodiazepine use, and multiple provider episodes 
and the odds of nonfatal overdose amongst injured workers with one or more opioid 
prescriptions? 
Hypothesis: Mean daily MME partially mediates the associations between more 
traumatic injuries, early initiation of opioid therapy, prior history of opioid use, long-
acting opioids, cash payment, combined opioid and benzodiazepine use, and multiple 
provider episodes and the odds of nonfatal overdose (MME is associated with overdose 
with OR>1 and ORs of other variables decrease but do not reach null after the inclusion 
of MME in the model).  
Methods 
Data sources and linking 
 In this nested case-control study, cases and controls were sampled from a retrospective 
cohort of injured workers in TN. Eligibility was reporting only one injury to TN WC, reporting a 
physical injury, having complete name, date of birth, and sex information on the WC record, and 
being 15-99 years old at the time of injury. Worker names and dates of birth were standardized 
and cleaned to remove prefixes, suffixes, and titles and separate multiple names into separate 
fields (i.e. FirstName, FirstName2, etc.). Workers were linked to their prescription history in the 
CSMD by deterministic matching on any first name, any last name, and date of birth as in the 
first study. Workers were additionally linked to their hospitalization and emergency room visits 
in HDDS and death certificate in Vital Statistics by deterministic matching on social security 
number. No workers had missing social security number. Prescription records, hospitalizations, 
and deaths were tracked for two years after injury.   
Case and control selection 
 Injured workers who had a record of an emergency department visit or hospitalization 
(both referred to hereafter as hospitalizations) for a nonfatal opioid-involved overdose during the 
three year follow up period after injury were defined as cases. Overdose was defined using ICD-
9 and ICD-10 codes: ICD-9 codes 965.02, 965.09, E850.1, E850.2 and ICD-10 codes T40.2, 
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T40.3, T40.4 for prescription opioids,  ICD-9 codes 965.01, E850.0 and ICD-10 code T40.1 for 
heroin, and ICD-9 code 965.00 and ICD-10 code T40.0 for opium (Centers for Disease Control 
and Prevention Prescription Drug Overdose Team, 2013). Overdoses were considered to be 
nonfatal if the patient was not deceased at the time of discharge or transfer. The case’s overdose 
date was the date of the first overdose that occurred during follow-up period.  
 Controls were matched to cases on sex, age ± 1 year, and overdose status. To begin 
matching, a control pool of all eligible controls was assembled for each case. Cases were ordered 
so that those with smaller control pools were matched first, and then simple random sampling 
was used to match five controls to each case. A 5:1 ratio was chosen to allow for 82% power to 
detect an odds ratio of 2.5 or greater at α=0.05 without reusing controls for more than one case. 
After being matched, that control was withdrawn from the control pools of all other cases so that 
each control was only matched to one case.  The control index date was the date of the matched 
case’s overdose. Controls did not have a nonfatal overdose during the study period and were 
alive at the time of their index date.    
Covariates  
Age at the time of injury, sex, type of injury, part of body injured, and address were 
obtained from WC records. County of residence was obtained by geocoding from address, and 
residence was categorized as urban (belonging to one of TN’s six metro regions) or rural (not in 
a metro region) based on TN Department of Health classifications (Tennessee Department of 
Health, Local and regional health departments). Marital status and industry were considered as 
demographic covariates, but were dropped from analyses when high missing values (45% for 
marital status and 97% for industry) were found. 
Variables for opioid use in the six months before overdose or index date and the month 
after injury were obtained from the CSMD and were measured in the six months before overdose 
or index date as well as the month after injury. Variables included maximum dose in morphine 
milligram equivalents (MME), receiving a long-acting opioid, visiting ≥2 prescribers or ≥2 
dispensers for opioids (6 months before overdose or index date, only), paying for an opioid with 
cash, receiving an opioid indicated for medically assisted treatment (MAT), and receiving a 
benzodiazepine. Opioids were included if they were for schedule II, III, or IV analgesics, and not 
dispensed from a veterinary or Veterans Affairs pharmacy to restrict prescriptions to a human, 
nonmilitary population.  Receiving an opioid indicated for MAT was correlated with having a 
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hospitalization for a substance use disorder, so the MAT flag was incorporated into the substance 
use hospitalization variable.  
The maximum dose in MMEs was included to measure the received dose of prescription 
opioids. Receipt of a long-acting opioid and receipt of a benzodiazepine were included due to the 
direct biological link between these variables and overdose: long-acting opioids stay in the body 
longer and increase the risk of overdose if another opioid is taken before the first dose has left 
the body (Braden, Russo, Fan, Edlund, Martin et al., 2010; Miller et al., 2015) and 
benzodiazepines depress respiration, especially in combination with opioids (Jann, Kennedy, & 
Lopez, 2014; Park et al., 2015). Visiting multiple prescribers and dispensers is included as a 
measure of high healthcare usage. Paying for an opioid with cash is included as a measure of 
doctor shopping. Receiving an opioid indicated for medically assisted treatment is a measure of 
an opioid use disorder. Receipt of muscle relaxants and stimulants in the six months before 
overdose or index date were measured to assess prescribing of controlled substances for other 
medical conditions close to overdose. 
Hospitalization and comorbidity variables were taken from HDDS. In addition to 
overdoses, ICD-9 and ICD-10 codes were used to identify hospitalizations and emergency 
department visits involving cancer, substance use disorders, anxiety disorders, depressive 
disorders, and bipolar or psychotic disorders (see Appendix 3, Table S3.1 for ICD codes). The 
Charlson Comorbidity Index, a 19-category weighted measure, was used to assign a composite 
comorbidity score (Quan, Sundararajan, Halfon, Fong, Burnand et al., 2005).  
Statistical analysis 
  Among cases, type of overdose and prescription history prior to overdose was described 
with frequencies, percentages, means, and standard deviations (SD). To compare demographic, 
injury, and prescription risk factors between cases and controls, the two groups were compared 
with frequencies, percentages, means, standard deviations, t-tests, chi square test (where cell 
sizes >5), Fisher’s exact test (where cell sizes ≤5). Statistical significance was defined in t-tests, 
chi square tests, and Fisher’s exact tests as p<0.05. Conditional logistic regression was used to 
calculate matched odds ratios (ORs) in bivariable models and in multivariable models while 
controlling for demographic characteristics, injury characteristics, and Charlson Comorbidity 
Score. An analysis of MME as a potential mediator was planned, but MME was very weakly 
associated with overdose and the study did not have enough statistical power to detect low odds 
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ratios. Instead, other hospitalizations occurring during the study period were identified and 
described by age group to shed light on common morbidities in injured workers.   
This study was approved by the Institutional Review Boards at the Tennessee Department 
of Health and University of Hawaii. SAS 9.4 was used for all analyses.  
Results 
The retrospective cohort included 50,651 injured workers who reported one injury to TN 
WC in 2013. Among these, 48,970 reported a physical injury and were able to be linked to their 
prescription history, 29,844 were TN residents, and 29,972 were 15-99 years old. These injured 
workers were matched to 323,873 hospital and emergency room visits, and 114 nonfatal 
overdoses among 101 workers were identified. The 101 cases were matched with 505 controls 
for a total sample size of 606 (Figure 3.1). 
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Figure 3.1: Study population flowchart 
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Among workers who overdosed, 72.3% (n=72) overdosed on prescription opioids, 10.9% 
(n=11) on heroin, 9.9% (n=10) on opium, and 7.0% (n=7) on both prescription opioids and 
heroin (Figure 3.2). Among prescription opioid overdoses, 9 (11.3%) overdoses identified 
methadone. Half (n=5) of the opium overdoses included medical procedures (3 dental work, 2 
surgery) as co-diagnoses. The most common co-diagnoses for overdoses were acute respiratory 
failure (33.7%, n=34), toxic encephalopathy (21.8%, n=22) and cerebral edema (8.9%, n=9). The 
mean amount of time between injury and overdose was 1.8 years ± 1.1 SD. 
Cases ranged in age from 18.1-73.6 years (mean 39.0 ± 12.64 SD) and controls ranged 
from 17.5-74.5 years (mean 39.0 ± 12.58 SD). Cases and controls were both 50.5% female. 
Cases were more likely than controls to have knee injuries (67.3% vs. 9.1%), cancer (6.9% vs. 
1.4%), a substance use disorder (48.5% vs. 29.7%), depression (19.8% vs. 9.9%), 
bipolar/psychotic disorder (9.9% vs. 2.4%), a positive Charlson comorbidity score (25.7% vs. 
18.6% for a score of 1 and 26.7% vs. 7.5% for a score of ≥2), a history of benzodiazepine 
prescriptions (31.7 vs. 10.3), and a history of muscle relaxant prescriptions (5.9% vs. 1.6%). 
Type of injury did not differ statistically between cases and controls, with strains, sprains, or 
tears being the most common (36.6% cases and 40.6% controls), followed by contusions (17.8% 
cases vs. 17.2% controls) and lacerations (13.9% cases and 12.1% controls) (Table 3.1).  
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Table 3.1: Comparison of demographic and clinical characteristics between nonfatal opioid overdose cases 
and controls (N=606) 
Characteristic 
Cases (n=101) Controls (n=505) 
n % n % 
Type of injury     
Other 32 31.7 152 30.1 
Strain, sprain, or tear 37 36.6 205 40.6 
Contusion 18 17.8 87 17.2 
Laceration 14 13.9 61 12.1 
Part of body injured     
Other * 13 12.9 348 68.9 
Lower back 12 11.9 62 12.3 
Finger(s) 8 7.9 49 9.7 
Knee * 68 67.3 46 9.1 
Region     
Rural 60 59.4 330 65.4 
Urban 41 40.6 175 34.6 
Comorbidities during 3 year follow-up     
   Cancer* 7 6.9 7 1.4 
   Substance use disorder (SUD)*
 
49 48.5 150 29.7 
   Anxiety disorder 14 13.9 62 12.3 
   Depression* 20 19.8 50 9.9 
   Bipolar/psychotic     
   disorder* 
10 9.9 12 2.4 
Charlson comorbidity score during 3 year follow-up     
   0* 48 47.5 373 73.9 
   1* 26 25.7 94 18.6 
   ≥2* 27 26.7 38 7.5 
Receipt of other drugs in 6 months before index date     
   Benzodiazepine* 32 31.7 52 10.3 
   Muscle relaxant* 6 5.9 8 1.6 
   Stimulant 2 2.0 13 2.6 
* p<0.05 
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Only 56 cases (55.4%) had a record of an opioid prescription within one month of 
overdose, 64 (64.6%) had a record within three months, and 72 (71.3%) had a record within six 
months. Among 72 cases who had a record for a prescription opioid within six months of 
overdose, 67 (66.3%) overdosed on a prescription opioid that was the same type as one that they 
had been prescribed, including seven who overdosed on a mix of a prescribed opioid and heroin. 
One worker overdosed on a prescription opioid that they did not have a prescription record for, 
and 12 workers overdosed on prescription opioids without having any history of having received 
any opioid legally within six months. An additional four workers overdosed on opium and had a 
corresponding prescription for opium (Figure 3.2).   
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Figure 3.2: Overdose type by prescription history 
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Among cases that had a prescription history in the six months prior to overdose, the mean 
of the largest daily dose received was 86.7 MMEs ± 60.27 SD and the mean of the largest day’s 
supply received was 32.1 ± 23.09 SD days. Over half of cases with a prescription record visited 
≥2 prescribers (n=43) or ≥2 dispensers (n=37) for opioids, a quarter received a long-acting 
opioid (n=18), and a third paid for an opioid with cash (n=24). Thirty-two received a 
benzodiazepine, a significantly greater proportion than that of controls (31.7% vs. 10.5%) (Table 
3.2).  
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Table 3.2: Estimated associations (odds ratios [ORs] and 95% confidence intervals [CIs] of demographic 
characteristics and type of injury with having an opioid-related overdose within 2 years of injury in injured 
workers who reported one injury to TN Workers’ Compensation 2013-2015 (N=606): Results from 
conditional logistic regression analyses. 
Opioid use pattern 
Cases  
(n=101) 
Controls 
(n=505) 
Unadjusted OR 
(95% CI) 
Adjusted
† 
matched OR 
(95% CI) n % n % 
Opioid analgesic use pattern in 6 months 
before overdose or index date 
72 71.3 0 0.0 Not included Not included 
   Max MME received mean (SD),  86.7 60.27 0.0 0.00 Not included Not included 
   Days’ supply received (SD) 32.1 23.09 0.0 0.00 Not included Not included 
   Received a long-acting opioid 18 17.8 0 0.0 Not included Not included 
   Visited ≥2 prescribers for opioids 43 42.6 0 0.0 Not included Not included 
   Visited ≥2 dispensers for opioids 37 36.6 0 0.0 Not included Not included 
   Paid for an opioid with cash  24 23.8 0 0.0 Not included Not included 
   Received benzodiazepine* 32 31.7 53 10.5 Not included Not included 
Opioid use in the month after injury* 56 55.5 199 39.4 2.1 (1.33-3.28) Not included 
   Early receipt of opioid (≤1 week   
    after injury) 
34 33.7 156 30.9 1.2 (0.74-1.85) 1.02 (1.00-1.04) 
   Max MME received mean (SD),  
   units=20* 
61.9 62.50 38.7 28.95 1.02 (1.01-1.04) 1.03 (1.01-1.05)* 
   Days’ supply received (SD),  
   units=7* 
9.6 12.4 3.8 7.33 1.01 (1.01-1.03) 1.9 (0.19-19.19) 
   Received a long-acting opioid * 10 9.9 7 1.4 8.1 (2.94-22.47) 1.0 (0.30-3.07) 
   Paid for an opioid with cash* 13 12.9 34 6.7 2.2 (1.08-4.42) 5.5 (0.87-35.21) 
   Received benzodiazepine* 15 14.9 13 2.6 8.2 (3.42-19.52) 3.9 (1.75-8.52)* 
Definitions: TN=Tennessee; OR=odds ratio; CI=confidence interval; SD=standard deviation; MME=morphine 
milligram equivalents 
* p<0.05 
† 
Adjusted odds ratios control for Charlson comorbidity score and receipt of an opioid in the six months before 
overdose or index date 
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Because no controls received an opioid analgesic in the 6 months before their index date, 
the month after injury was chosen as the time frame for measuring prescriptions for the 
multivariable analysis. Cases had significantly more opioid use in the month after injury (33.7% 
vs. 30.9%, left out of the multivariable to avoid confounding with other opioid variables) than 
controls. In bivariable models, overdose was associated with receiving a long-acting opioid 
(OR=8.1, 95% CI 2.94-22.47), paying for an opioid with cash (OR=2.2, 95% CI 1.08-4.42), and 
receiving a benzodiazepine (OR=8.2, 95% CI 3.42-19.52) while day’s supply (OR=1.01, 95% CI 
1.01-1.03 for every increase in 7 days’ supply) and the maximum received daily MME 
(OR=1.02, 95% CI 1.01-1.04 for every increase in 20 MME) were weakly associated. After 
adjusting for Charlson comorbidity score, associations were no longer significant except for 
daily MME (OR=1.03, 95% CI 1.01-1.05 for every increase in 20 MME) and benzodiazepines 
(OR=3.9, 95% CI 1.75-8.52). When MME was classified as a dichotomous variable with values 
≥100 MME or <100 MME, it was no longer associated with overdose. Paying for an opioid with 
cash was not associated.  
After surviving a nonfatal overdose, 58 cases had a record of receiving a prescription 
opioid within six months after injury. This included 54 cases who had a prescription record in the 
month before injury. All but six cases (n=52) received an opioid of the same type that they had 
been prescribed before, and only three cases had decreased dosage after overdose (mean -11.7 
MMEs ± 10.23 SD). The remaining 49 cases continued receiving the same type and dosage of 
opioid as they had received before overdose.  
Although only the first overdose was analyzed, 8.9% of cases (n=9) had a subsequent 
overdose during the study period. The mean amount of time between the first and second 
overdoses was 18.9 weeks ± 20.00 sd. Seven people had two overdoses during the study period, 
one person had three overdoses, and one person had five overdoses. This person experienced 2 
heroin overdoses and 3 prescription opioid overdoses over 11 months. 
Nine cases had fatal drug overdoses during the study period (eight had ≥2 nonfatal 
overdoses before a fatal overdose and one had a single nonfatal overdose before a fatal 
overdose). Four died from prescription opioids, 1 died from heroin, 2 died from non-opioid 
narcotics, 1 died from antidepressants, and 1 died from chronic viral hepatitis C and 
psychoactive substance abuse. Two controls died: 1 from nonrheumatic (aortic) valve stenosis 
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and 1 from acute myocardial infarction. Both controls died after their corresponding case’s date 
of overdose (index date) and were not removed from the study.  
In the parent cohort, the most common injuries for 15-29 year olds were abdominal pain 
(2.8% of hospitalizations), chest pain (2.2%), and urinary tract infection (1.2%). The most 
common injuries for 30-59 year olds were chest pain (4.5%), abdominal pain, (2.3%), and 
headache (1.9%). The most common injuries for workers aged 60 years and older were chest 
pain (3.3%), screening for malignant neoplasms of colon (2.3%), and atherosclerotic heart 
disease (1.2%) (Supplement Table S3.2) 
Discussion 
In this case-control study of 27,972 injured workers, 101 workers with a nonfatal 
overdose were found over a three year follow-up period and almost half of cases (44.6%) did not 
have a record for an opioid prescription in the month before overdose. The overdose rate appears 
to be lower than the overdose rate in the overall TN population. The most recently available data 
show that TN had 7,092 inpatient stays (rate of 107.4 per 100,000 persons) and 13,034 outpatient 
visits (rate of 197.5 per 100,000 persons) for nonfatal opioid overdoses in 2015 (i.e. over a one 
year period) (Tennessee Department of Health, Data Dashboard). In the parent cohort of this 
study, the cumulative incidence of nonfatal overdose was 380 cases per 100,000 persons over a 
three year period. WC populations in other states show similarly low rates of overdose. In a 
cohort study of Washington State WC, 92 deaths and 312 adverse events due to opioids were 
found over six years of observation, although this study was held in 2004-2010 when the opioid 
epidemic was less severe in all states (Fulton-Kehoe et al., 2013).  
Opioid prescribing and hospitalization patterns prior to overdose show three main groups 
of workers who overdosed: people with a prescription history (including people with cancer, 
mental health diagnoses, and/or high healthcare usage) and people without a prescription history 
and possibly involved in drug diversion.  
This study supports a link between prescribing and overdose. Risk factors such as higher 
dose and use of benzodiazepines come as no surprise due to increasing drug toxicity and the 
combined depressive effect of opioids and benzodiazepines on the cardiovascular system (Chen 
& Ashburn, 2015). Compared to controls who received virtually no opioids before their index 
date, prescribing to cases was characterized by dangerously high doses and days’ supplies. 
Among cases with a history of opioid prescriptions before overdose, 40% received a dose over 
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the 90 MME threshold designated by the TN chronic pain guidelines as indicating referral to a 
pain specialist, and 55% received a days’ supply that was over the 30 day legal limit in TN 
("Prescription Safety Act of 2012," 2012). Almost all of the cases who had a record for an opioid 
prescription in the month before overdose received another opioid prescription within six months 
after overdose. The high post-overdose prescribing in this study has been shown in other 
populations, such as in a large U.S. health insurer population where 91% of nonfatal overdose 
patients received another prescribed opioid within two years (Larochelle, Liebschutz, Zhang, 
Ross-Degnan, & Wharam, 2016). Automatic alerts to prescribers when one of their patients is 
hospitalized for an overdose (under development by the TN Department of Health) may help 
alert prescribers when a patient needs increased attention or a change in treatment.  
For the nine cases who died of an overdose after surviving a nonfatal overdose, this 
supports suggestions that the encounter with healthcare that occurs during an overdose is not 
being effectively utilized as an intervention point (Frazier, Cochran, Lo-Ciganic, Gellad, Gordon 
et al., 2017). By one recent study’s estimate, injection drug users in Vancouver who are brought 
to the hospital for a nonfatal overdose have 95% higher hazards of having a later fatal overdose 
than drug users who do not have a documented nonfatal overdose (HR= 1.95, 95% CI 1.17-3.27) 
(Caudarella, Dong, Milloy, Kerr, Wood et al., 2016), indicating that this is a particularly 
vulnerable group. Additionally, although HDDS records do not contain enough information to 
identify the place that an overdose occurred or what circumstances surround it, the five opium 
overdoses that were accompanied with medical procedure co-diagnoses raise the question of 
whether these overdoses occurred in medical settings, perhaps through human error during or 
after procedures. In-hospital opioid overdose have also been noted elsewhere (Cauley, Anderson, 
Haynes, Menendez, Bateman et al., 2017).  
For cases with a prescription history, it is easy to call for a crackdown on prescribers who 
supply the drugs and regulating prescribing to prevent overdose has been a common approach 
("Prescription Safety Act of 2012," 2012), with demonstrated success on a population level (Al 
Achkar, Grannis, Revere, MacKie, Howard et al., 2018). However, many cases in this study had 
a prescription history but disappeared from the dataset a few months before overdose. It is 
unknown what happened to these cases between their last prescription and their date of overdose, 
especially since many of them overdosed on a prescription opioid, but others have suggested that 
patients may turn to more dangerous illicit supplies of opioids when they are cut off by their 
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prescribers (Tedesco, Asch, Curtin, Hah, McDonald et al., 2017). Opioids available on illicit 
markets are often counterfeit or cut with fentanyl, making it difficult to judge their potency 
before they are consumed (Pergolizzi, LeQuang, Taylor, & Raffa, 2018). Improving naloxone 
distribution, safe injection sites, and other harm reduction approaches is needed (Rudd et al., 
2016), and this study provides support for arguments that access to prescription opioids should 
be maintained in certain cases of dependence (Compton, Jones, & Baldwin, 2016).  
Charlson comorbidity score was a confounder in the association between several opioid 
use patterns and overdose, suggesting that overall healthcare usage, especially for cancer and 
mental health diagnoses, is a key variable associated with overdose. This association is repeated 
in other studies, notably in a recent meta-analysis where drug overdose death in the United States 
was most strongly associated with a history of substance use disorders (OR=5.24, 95% CI 3.53-
7.76) and psychiatric disorders (OR=3.94, 95% CI 3.09-5.01) (Brady, McCauley, & Back, 2016). 
This study provides a detailed description of the clinical and prescribing characteristics of 
opioid overdose by injured workers and sheds light on the complex relationship between opioid 
prescribing and overdose as well as what happens after overdose. Workers who experienced an 
opioid overdose often had no prescription history prior to overdose or had a prescription history 
but no records for prescriptions within a month of overdose. Charlson comorbidity score 
confounded associations between opioid use and overdose except for benzodiazepine use and 
MME, which was weakly associated at an OR below that which the study had 80% power to 
calculate. There was a high rate of repeat overdoses with ten cases (9.9%) suffering a subsequent 
nonfatal and/or fatal overdose. The results of this study have high applicability to TN but may 
not be generalizable to other states. 
Limitations  
Several of the major insurance companies in TN exclude drug overdose hospitalizations 
from coverage (Liveoak, 2017) so hospitals have an incentive to underreport overdose and it is 
likely underestimated by using HDDS, a dataset intended for billing, to define cases in this study. 
Other states have noted suspected overdoses being coded as cardiac arrest in hospital discharge 
records (Slavova, Bunn, & Talbert, 2014). Chest pain, the most frequent cause of hospitalization 
in ages 30-59 and 60-99 years old of the parent cohort and the second most frequent in ages 15-
29 years, may include some overdose cases that were not captured by the overdose definition. 
Effect estimates are not expected to be biased as misclassification error for overdoses is 
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nondifferential between opioid use groups. However, effect sizes of opioid use variables, 
especially MME and days’ supply, may be biased towards the null by failing to account for 
opioids that were obtained through illicit markets. There is particularly concern about opioids on 
illicit markets being cut with fentanyl, a cheaply manufactured synthetic opioid that is 80 times 
more powerful than morphine (National Institute on Drug Abuse, 2017). 
Survival bias is introduced by excluding controls who died of another cause during the 
study period and requiring cases to have survived long enough to have an overdose, and is 
expected to affect odds ratios by causing underestimates.  With a long follow up period, results 
are also more vulnerable to confounding by chronic opioid use. For example, increasing drug 
tolerance is a side effect of chronic opioid use, so while high doses are characteristic of 
overdoses in chronic users, the overdose may be more attributable to the introduction of another 
drug or sudden modulations in substance use rather than the size of the prescribed dose (Glanz, 
Narwaney, Mueller, Gardner, Calcaterra et al., 2018; Witkiewitz & Vowles, 2018), decreasing 
the effect size of MME on overdose. 
Conclusions 
A healthy worker effect was found in injured workers in TN, who had a lower incidence 
of nonfatal opioid-involved overdose than the overall TN population. Among injured workers 
who overdosed, most had received a prescription opioid within six months of overdose 
(compared to 0% of controls). A concerning trend of “disappearing” from the prescription opioid 
database in the months before overdose was noted, possibly indicating migration to illicit 
markets when prescriptions can no longer be obtained. Increasing odds of overdose were found 
with increasing dose received in the month after injury, implying that opioids prescribed after 
injury may lay the groundwork for future outcomes. Caution is needed in initiating new patients 
to opioid use and discontinuation of opioid use should be treated thoughtfully, with treatment 
and harm reduction options available for patients with suspected opioid use disorder.  
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Chapter 4 
 A predictive model for injury as a gateway to long-term opioid use: A retrospective cohort 
study using linked statewide databases in Tennessee. 
Abstract 
Background  Opioids are unsurpassed at treating acute pain, but become increasingly harmful 
when used for long periods. Injury has been documented as a gateway to opioid use in some 
populations but not injured workers in Tennessee (TN). 
Objective  A retrospective cohort study was conducted to evaluate the prevalence of and risk 
factors for developing long-term opioid use after injury among workers who were opioid-free 
before injury and reported an injury to the TN Bureau of Workers’ Compensation (WC) March 
2013 – December 2015. 
Methods  Injured workers who reported only one injury to TN WC 2013-2015 were identified in 
WC records and matched to their prescription history in TN’s prescription drug monitoring 
program. Injured workers who were opioid-free at the time of injury and between the ages of 15 
and 99 years were included in analyses. Long-term opioid use was defined as receiving opioids 
on greater than or equal to 45 days in the 90 days after injury, and associations between long-
term use and demographic, injury, and opioid use variables were calculated with bivariable and 
multivariable unconditional logistic regression yielding odds ratios (ORs) and 95% confidence 
intervals (CIs). A derivation model (including workers injured March 2, 2013 – December 31, 
2014) was used in model development and a validation model (including workers injured 
January 1, 2015 – December 31, 2015) was used in testing the model’s predictive ability.  
Results  The final sample was 46,399 injured workers who were opioid-free at the time of injury 
and received opioids after injury, 1,843 (4%) of whom became long-term opioid users after 
injury. The odds of long-term opioid use increased 30% when 5-9 days’ supply was given in the 
initial prescription compared to <5 day’s supply (95% CI 1.18-1.47). However, long-term use 
was most strongly associated with receiving ≥20 days’ supply in the initial opioid prescription 
(odds ratio [OR]=32.2, 95% confidence interval [CI] 28.91-35.85), followed by receiving a long 
acting opioid within 30 days of injury (OR=6.6, 95% CI 5.34-8.08), visiting ≥3 prescribers 
(OR=6.9, 95% CI 5.82-8.23), and visiting ≥3 pharmacies (OR=6.0, 95% CI 4.67-7.70) after part 
of body injured, overlapping opioid and benzodiazepine prescriptions, and maximum MME 
received within 30 days of injury were controlled for.  
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Conclusion  Injury is a gateway to long-term opioid use in a vulnerable set of injured workers. 
Risk for developing long-term use appears to be more tied to opioid prescribing than 
demographic characteristics.   
Background 
Long-term opioid use is about more than the number of days on which someone takes an 
opioid: it is about the threshold at which the costs of opioid use begin to outweigh the 
advantages. While opioids are unsurpassed at treating acute pain, evidence increasingly indicates 
that opioids are not effective at managing chronic pain (Turk, 2002). In some studies, long-term 
opioid use is associated with increased or equivalent reports of pain compared to baseline, 
possibly due to a developing tolerance to the opioid (Eriksen et al., 2006; Trang et al., 2015) or 
increased pain sensitivity (Angst & Clark, 2006; Mao, Sung, Ji, & Lim, 2002). Most concerning, 
however, is that long-term opioid use has been documented as a precursor to the use of heroin 
and other illicit opioids, possibly because of illicit drugs’ greater affordability and availability 
(Palamar et al., 2016). In injured workers, chronic opioid therapy is associated with higher 
healthcare costs (Johnston, Alexander, Masters, Mardekian, Semel et al., 2016) and poor return 
to work rates (Anderson, Haas, Percy, Woods, Ahn et al., 2016). 
The most rigorous recent research on long-term opioid use was summarized in a 
systematic review for a National Institutes of Health workshop. This review found no evidence 
of effectiveness for opioid use of greater than three months, but increased risk of harms including 
overdose, drug abuse, fractures, myocardial infarction, and use of drugs used to treat sexual 
dysfunction (Chou, Turner, Devine, Hansen, Sullivan et al., 2015) and is supported by an earlier 
review showing that evidence linking long-term opioid use to improvements in pain and function 
is weak (Manchikanti, Vallejo, Manchikanti, Benyamin, Datta et al., 2011). The workshop 
review may have concluded even greater harms from long-term opioid use had it included non-
controlled studies, which show that long-term opioid use is associated with dependence and 
addiction, poor self-rated health, inactivity, unemployment, higher healthcare utilization, and 
poor self-rated quality of life (Eriksen et al., 2006). Some non-opioid treatments, in contrast, 
have been shown to be effective in managing chronic pain without the side effects associated 
with analgesic treatment (Gatchel & Okifuji, 2006) and with the same or better pain outcomes as 
opioids (Eriksen et al., 2006).  
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In previous research, injury has been documented as a gateway to opioid use in athletes 
(Cottler, Ben Abdallah, Cummings, Barr, Banks et al., 2011; Veliz, Epstein-Ngo, Meier, Ross-
Durow, McCabe et al., 2014) and people who have experienced car crashes (Berecki-Gisolf, 
Hassani-Mahmooei, Collie, & McClure, 2016). Surgery has similarly been documented as a 
gateway to long-term opioid use (Alam, Gomes, & Zheng, 2012; Johnson, Chung, Zhong, 
Shauver, Engelsbe et al., 2016a) but also identified as an opportunity for opioid weaning (Inacio 
et al., 2016). Research on risk factors shows strong evidence that pre-existing substance use and 
mental health disorders increase the likelihood of developing long-term opioid use (odds ratio 
[OR]=1.46, 95% confidence interval [CI] 1.12-1.91 for mental health diagnoses and (OR=2.34, 
95% CI 1.75-3.14), for substance abuse vs. no diagnosis in Veterans Affairs patients), 
(Brummett, Waljee, Goesling, Moser, Lin et al., 2017; Sun, Darnall, Baker, & Mackey, 2016).  
Evidence on demographic risk factors, however, has not reached consensus and at times 
is directly contradictory. For example, in two studies of opioid use after surgery in previously 
opioid-free patients, one found that males and people older than 50 years were at highest risk of 
long-term opioid use while the other showed females and younger age groups at highest risk 
(Johnson et al., 2016a; Sun et al., 2016). In veterans, which may be a more comparable 
population to injured workers, males, younger age groups, and people with mental health 
disorders are most vulnerable to developing long-term opioid use (Edlund, Steffick, Hudson, 
Harris, & Sullivan, 2007), and in Oregon, rural residents have higher odds of long-term opioid 
use than urban residents (OR=1.37, 95 % CI 1.34-1.41) (Deyo, Hallvik, Hildebran, Marino, 
Dexter et al., 2017).  
In workers, patterns of prescribing soon after injury have been linked to later long-term 
opioid use (Fritz, King, & McAdams-Marx, 2017). A recent MMWR article pointed to the days’ 
supply of the initial prescription as the single largest factor in later long-term opioid use after 
dose was controlled for (Shah, Hayes, & Martin, 2017). Two other cohort studies of injured 
workers with back injuries found that higher daily dose, measured in morphine milligram 
equivalents (MME), in the first three months after injury is strongly predictive of long-term 
opioid use after baseline pain and injury severity is controlled for (Franklin et al., 2009; Webster 
et al., 2007). Links between long-term opioid use and dose escalation have also been noted 
(Cifuentes et al., 2010; Franklin et al., 2009). 
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There are several definitions for long-term opioid use. The Centers for Disease Control 
and Prevention (CDC) defines long-term opioid use as receiving opioids on most days for greater 
than or equal to 3 months (Dowell et al., 2016). In contrast, previous research on injured 
workers, including WC claimants, has defined long-term opioid use as receiving an opioid in 
each quarter for a year after injury (Franklin et al., 2009), receiving greater than or equal to five 
opioid prescriptions from 30 to 730 days after injury (Webster et al., 2007), and receiving an 
opioid for greater than three months (Heins, Feldman, Bodycombe, Wegener, & Castillo, 2016). 
The CDC’s definition, referred here as “3-month continuous use,” is consistent with 
definitions of chronic pain in the Tennessee Chronic Pain Guidelines and CDC Chronic Pain 
Guidelines, which define chronic pain as pain lasting longer than 90 days (Dowell et al., 2016; 
Tennessee Department of Health, 2014). However, this definition may have less clinical 
applicability in a WC setting than in the surgical settings for which it was derived. In a surgical 
setting, the extent of tissue damage is controlled and anti-infection measures are taken to 
minimize recovery time. In a WC setting, the extent of tissue damage is uncontrolled and often 
involves longer-healing injuries such as tears and breakages. Additionally, infection and the 
introduction of foreign bodies to a wound may additionally increase recovery time, and surgery 
scheduled in the weeks and months after an injury may additionally increase the time that a 
patient spends on opioids. In this context, we anticipate that a 90-day threshold after injury will 
be too conservative and will capture fewer cases than a threshold further after injury.  
The definitions used in occupational medicine research are unstandardized but are often 
longer than 3 months. These definitions accommodate the protracted treatment of acute pain after 
injury and encapsulate the continuity of therapy which is an essential feature of long-term opioid 
use. However, a common definition is needed to allow comparability between studies. This study 
will evaluate the appropriateness of different definitions and construct a predictive model for 
long-term opioid use in previously opioid-free injured workers with the following research 
questions and hypotheses: 
RQ 4.1: What percentage of injured workers are opioid-free at the time of their injury? 
Hypothesis: More than half (>50%) of injured workers are opioid-free at the time of their 
injury. 
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RQ 4.2: Among injured workers who were opioid-free at the time of injury but who received an 
opioid in the month after injury, does a three or four month follow-up period capture more cases 
of long-term opioid use?  
Hypothesis: Measuring opioid use as receiving an opioid on most days in a four month 
period captures more cases than measuring opioid use as receiving an opioid on most 
days in a three month period.  
RQ 4.3: What demographic factors (sex, age, residence area, injury type, and part of body 
injured) and opioid use patterns (early initiation of opioid therapy, combined opioid and 
benzodiazepine use, long-acting opioids, higher mean daily MME, higher day’s supply, multiple 
prescribers and pharmacies, cash payment) predict a previously opioid-free injured worker 
developing long-term opioid use after injury? 
Hypothesis: Female sex, middle age group, residence in east TN, more traumatic injuries, 
early initiation of opioid therapy, long-acting opioids, higher mean daily MME, using 
multiple prescribers and pharmacies, and cash payment predict long-term opioid use 
(ORs>1). Part of body injured does not predict long-term opioid use (OR=1).  
Methods 
 We used data from TN WC and CSMD records, cleaned and linked as described in 
Chapters 2 and 3. To allow for prescriptions to be measured from 60 days prior to injury through 
180 days after injury, prescription records were accessed from January 1, 2013 – April 30, 2016 
and WC records were accessed from March 2, 2013 – December 31, 2015.  
Study population 
     The main study population was injured workers who were opioid-free at the time of 
injury, defined as having no record of receiving an opioid prescription for 60 days prior to injury. 
As in Study 1, eligibility was having complete name, date of birth, and sex data in the WC record 
to enable matching to the CSMD, having a physical injury, and being aged 15-99 years. To avoid 
the confounding effect of multiple injuries, eligibility was restricted to injured workers who 
reported no more than one injury during the study period. Opioid prescriptions were included if 
they were class “opioid” and schedule 2-4, and excluded if they were indicated for medication-
assisted therapy, or dispensed by a veterinarian or Veterans Affairs pharmacy. Opioid 
prescriptions were measured from 60 days prior to each person’s date of injury (earliest January 
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1, 2013) to 120 days after each person’s injury (latest April 30, 2016). Injured workers who 
received opioids after injury but were opioid-free before injury were selected for analysis.  
Demographics and clinical information 
 Age at the time of injury, sex, marital status, type of injury, part of body injured, and 
residence type were selected from WC records based on availability, completeness, and previous 
literature. Type of injury was categorized into strains, sprains, and tears, fractures, and other 
based on frequency and association with long-term opioid use. Part of body injured was lower 
back, finger(s), knee, and other based on frequency and association with long-term use. 
Residence type was identified from zip codes and classified as urban (residing in a county with 
one of TN’s 6 largest cities) or rural (residing in one of the other 89 counties).  
After linking to the CSMD, opioids and benzodiazepines received in the 60 days prior to 
injury were flagged. Post-injury opioids were flagged for long-acting opioids, cash payment, and 
overlapping opioid and benzodiazepine prescriptions, maximum daily dose in morphine 
milligram equivalents (MMEs), and maximum days’ supply were noted. Each prescription flag, 
dose, and days’ supply was completed for 7, 30, and 90 days after injury. Additionally, the dose 
in MMEs and days’ supply of the first prescription were identified, receiving a benzodiazepine in 
the 60 days prior to injury was flagged, and the number of prescribers and pharmacies visited 
within the first 90 days of injury were calculated. For workers with ties for the first prescription 
received, MME and days’ supply were summed for all eligible opioid prescriptions received on 
that day. Opioid use variables were chosen based on availability. 
Primary outcome 
 The primary outcome of this study was long-term opioid use. Long-term opioid use was 
measured with prescription days, i.e. the days’ supply of an opioid added to the date on which 
the opioid was received. For example, a prescription received on January 1 with 10 days’ supply 
has prescription days on January 1 – 10. For overlapping prescriptions, prescription days were 
only counted once. Two definitions were assessed: 1) the CDC definition of receiving an opioid 
on most days for a 90 day period, measured as ≥45 prescription days in the 90 days after injury, 
and 2) a novel definition of receiving an opioid on most days in a 120 day period, measured as 
≥60 prescription days in the 120 days after injury, to account for opioids received after a delay.  
   
 
59 
 
Statistical analysis 
The sample of opioid-free injured workers was split so that people with injuries occurring 
in 2013 and 2014 were used for the derivation model and the last year was kept separate for use 
in validating the derivation model. Frequencies and percentages were used to describe the 
distribution of demographic and clinical characteristics in the population. Opioid-free injured 
workers were compared with non opioid-free injured workers. 
The two definitions of long-term opioid use were compared by calculating the number of 
injured workers identified as cases by each time frame, and the definition that captured the 
greatest number of cases was chosen for use in analyses. To identify associations with long-term 
opioid use, we used chi squared test to compare sample percentages and unconditional logistic 
regression to compute unadjusted and adjusted odds ratios (ORs) with 95% confidence intervals 
(CIs).  
  To build the derivation model, demographic and clinical variables that showed an 
association (CIs do not overlap 1) with long-term opioid use in unadjusted models were selected 
for inclusion in a multivariable model. Where different time frames had been considered for 
opioid-use measures (e.g. long-acting opioid received within 7 vs. 30 vs. 90 days of injury), the 
time-frame with the highest associated point estimate was included in the starting multivariable 
model. The multivariable model was refined with feedback from ROC curves to maximize model 
fit, systematically changing variables and time frames to maximize ROC curve. After the best-
fitting derivation model had been achieved, the model parameters were applied to the validation 
group to form the validation model, and the validation model fit and associations were compared 
to the derivation model. SAS 9.4 was used for all analyses. This study was approved by the 
Institutional Review Boards at the Tennessee Department of Health and University of Hawaii.  
Results 
Demographics and opioid-free status 
Of 205,798 injured workers who reported one injury to TN WC, 128,885 met eligibility 
criteria, and 58,278 received opioids in the 90 days after injury. Among injured workers who 
received opioids, 79.6% (n=46,399) were opioid-free at the time of injury (Table 4.1). Most 
(82.1%, n=38,080) received their first opioid within a month of injury, but 17.9% received their 
first opioid 30-90 days after injury. Approximately 4% of the opioid-free group (n=1,834) 
became long-term users, and 653 (1.7%) had sustained opioid use throughout the 90 days after 
injury (i.e. received an opioid on most days for each of the three months).  
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Compared to injured workers with a recent history of opioid use before injury, opioid-
free injured workers were more likely to be less than 35 years old (34.8% vs. 24.0% in the 
derivation model), male (57.8% vs. 48.8%), injured with fractures (9.0% vs. 5.5%), injured on 
the fingers (10.2% vs. 7.5%), and from urban areas (38.2% vs. 31.7%) (Table 4.2). 
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Table 4.1: Sample selection methodology and description of sample size, by model 
Study selection criteria 
Derivation model 
(March 2, 2013- December 31, 2014) 
Validation model (January 1, 2015 
– December 31, 2015) 
Injured workers who reported only 
one injury to TN Workers’ 
Compensation 2013-2015 
133,542 72,256 
Injury type indicates a physical 
injury 
132,112 71,672  
Able to be linked to prescription 
history (not missing name, sex, or 
date of birth) 
132,112 71,672  
15-99  years of age 83,853 45,032 
Received an opioid within 90 days 
of injury 
38,646 19,632 
Opioid-free at the time of injury 
and included in analysis 
30,608 15,791 
Definitions: TN=Tennessee 
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Table 4.2: Demographic and clinical characteristics of injured workers who reported one injury to TN 
Workers’ Compensation from March 2 2013 – December 31, 2015 and received opioids within 90 days of 
injury (N=58,278), by model and opioid-free status at time of injury  
Characteristic 
Derivation Model  Validation model  
Opioid free Opioid free 
No (n=8038) Yes (n=30608) No (n=3841) Yes (n=15791) 
n % n % n % n % 
Age (years)         
15 – 34 1925 24.0 10663 34.8 839 21.8 5550 35.2 
35-54 4278 53.2 14121 46.1 2041 53.1 7074 44.8 
55-99 1835 22.8 5824 19.0 961 25.0 3167 20.1 
Sex         
Female 4117 51.2 12921 42.2 2015 52.5 6618 41.9 
Male 3921 48.8 17687 57.8 1826 47.5 9173 58.1 
Marital status         
Single 188 2.3 694 2.3 88 2.3 303 1.9 
Married 2403 29.9 8749 28.6 1079 28.1 4240 26.9 
Widowed, separated, or 
divorced* 
1796 22.3 6561 21.4 1012 26.4 3841 24.3 
   Missing / unknown 3651 45.4 14604 47.7 1662 43.3 7407 46.9 
Type of injury         
Strain, sprain, or tear 3193 39.7 11994 39.2 1480 38.5 5839 37.0 
Fracture 439 5.5 2755 9.0 214 5.6 1596 10.1 
Other 4406 54.8 15859 51.8 2147 55.9 8356 52.9 
Part of body injured         
Lower back 965 12.0 3723 12.2 458 11.9 1791 11.3 
Finger(s) 603 7.5 3118 10.2 279 7.3 1524 9.7 
Knee 635 7.9 2465 8.1 309 8.0 1246 7.9 
Other 5835 72.6 21302 69.6 2795 72.8 11230 71.1 
Residence type         
Rural 5490 68.3 18927 61.8 2627 68.4 9847 62.4 
Urban 2548 31.7 11681 38.2 1214 31.6 5944 37.6 
Definitions: Opioid-free at the time of injury=no record of opioid use in the 60 days prior to injury; Long-term 
use=receiving an opioid on most days in the 90 day period after injury; TN=Tennessee 
*All comparisons between non opioid free and opioid free injured workers were significantly different at p<0.05  
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Long-term opioid use 
Of the two definitions of long-term opioid use that were tested, the definition of receiving 
an opioid for most days in a 90 day period captured the most cases (1,834 vs 1,612 captured by 
the definition of receiving an opioid for most days in a 120 day period) and was selected for use 
throughout remaining analyses (Appendix 4, Table S4.1). The number of injured workers who 
received an opioid on most days decreased sharply between the first and second month after 
injury, decreased between 31 and 150 days after injury with a slight slowing in the rate of 
decrease in the 61-90 day period, and plateaued around 150-180 days after injury (Chart 4.1). 
Expanding the definition to receiving an opioid for most days in a 120 day lost 824 people whose 
opioid use waned after 90 days, even as it added 684 cases who did not have enough opioid use 
in the first 90 days to qualify for the 90-day definition (Appendix 4, Table S4.1). 
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Figure 4.1: Number of injured workers receiving opioids on most days, by 30-day time period 
after injury among workers who were opioid-free at the time of injury and received opioids 
within 90 days of injury (n=46,399)  
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The derivation model included 30,608 injured workers and the validation model included 
15,789. Because of small cell size, categories for days’ supply and daily MME were collapsed 
and marital status was not included in the models.  
 The derivation model and validation model found similar effects for all variables except 
that finger injuries were not significantly associated (CI overlapped 1) in the validation model 
and receiving ≥20 days’ supply in the initial opioid prescription was associated at reduced 
magnitude in the validation model (OR=18.4, 95% CI 15.95-21.23) compared to the derivation 
model (OR=32.2 95% CI 28.91-35.85) (Table 4.3). Long-term opioid use was most strongly 
predicted by receiving ≥20 days’ supply in the initial opioid prescription, followed by receiving a 
long acting opioid within 30 days of injury (OR=6.6, 95% CI 5.34-8.08), visiting ≥3 prescribers 
(OR=6.9, 95% CI 5.82-8.23), visiting ≥3 pharmacies (OR=6.0, 95% CI 4.67-7.70) after part of 
body injured, overlapping opioid and  benzodiazepine prescriptions, and maximum MME 
received within 30 days of injury were controlled for. Cash payment was not associated with 
long-term use. Lower odds of long-term opioid use were found in finger injuries compared to 
other body parts (OR=0.7, 95% CI 0.60-0.82), urban residence compared to rural residence 
(OR=0.6, 95% CI 0.58-0.69), and receipt of an opioid within 7 days of injury compared with not 
receiving an opioid within 7 days (OR=0.5, 95% CI 0.45-0.53). See Appendix 4, Table S4.2 for 
cell sizes and Appendix 4, Table S4.3 for derivation model unadjusted odds ratios. 
Although long-term opioid use was associated with sex in bivariable analyses (OR=1.4, 
95% CI 1.26-1.60 for males vs. females), sex had an inconsequential effect on derivation model 
fit and its inclusion did not change associations with other variables. Ages 55-99 years were 
associated with long-term use in bivariable models (OR=1.9, 95% CI 1.63-2.27) but the 
association decreased (to OR=1.2, 95% CI 1.11-1.43) in multivariable models. The derivation 
model fit improved when age was removed while associations between other variables and 
opioid use were unchanged. Although type of injury was associated with long-term opioid use in 
bivariable models (OR=1.14, 95% CI 1.04-1.24 vs. for strains, sprains, and tears vs. “Other” 
injuries and OR=0.78, 95% CI 0.68-0.90 for fractures vs. “Other” injuries), its inclusion in the 
derivation model resulted in changing the model fit from 0.895 to 0.896. This was deemed to be 
an inconsequential change and type of injury was removed from the model for the sake of 
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parsimony. Benzodiazepine use before injury was not included in multivariable models because 
it was correlated with overlapping opioid and benzodiazepine prescriptions after injury.   
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Table 4.3: Estimated adjusted associations (odds ratios [ORs] and 95% confidence intervals [CIs] of 
demographic, injury, and opioid use variables with long-term opioid use after injury in injured workers who 
reported one injury to TN Workers’ Compensation and were opioid-free at the time of injury: Results from  
unconditional logistic regression analyses. 
Characteristic 
Derivation model  
(n=30,608; c=0.91) 
Validation model  
(n=15,791; c=0.89) 
Adjusted
†
 
OR 
95% CI Adjusted
†
 
OR 
95% CI 
lower upper lower upper 
Part of body injured       
Other ref   ref   
Lower back 1.1* 1.02* 1.29 1.4** 1.16 1.59 
Finger(s) 0.7** 0.60 0.82 0.8 0.58 2.04 
Knee 1.0 0.83 1.11 1.1 0.78 2.30 
Residence type       
Urban ref   ref   
Rural 1.3** 1.26 1.37 1.3** 1.22 1.41 
Receipt of an opioid within 7 days of injury 0.5** 0.45 0.53 0.4** 0.36 0.45 
Days’ supply of first prescription       
     <5 ref   ref   
5-9 1.3** 1.18 1.47 1.3** 1.13 1.51 
10-19 3.0** 2.60 3.50 2.5** 2.06 3.15 
≥20 32.2** 28.91 35.85 18.4** 15.95 21.23 
Long-acting opioid within 30 days of 
injury 
6.6** 5.34 8.08 3.4** 2.93 3.95 
Overlapping opioid and benzodiazepine 
prescription days within 30 days of injury 
3.9** 3.49 4.34 1.3** 1.13 1.51 
Number of prescribers visited for opioids 
within 90 days of injury 
      
   1 ref   ref   
   2 2.1** 1.90 2.33 1.9** 1.69 2.23 
   ≥3 6.9** 5.82 8.23 6.1** 4.80 7.69 
Number of pharmacies visited for opioids 
within 90 days of injury 
      
   1 ref   ref   
   2 1.6** 1.47 1.81 1.8** 1.57 2.08 
   ≥3 6.0** 4.67 7.70 3.0** 1.98 4.54 
Maximum MME received within 30 days 
of injury 
      
   <40 ref   ref   
   40-99 1.9** 1.77 2.12 2.0** 1.74 2.21 
100-159 1.5** 1.26 1.89 1.6** 1.22 2.14 
 ≥160 3.7** 2.74 4.92 3.0** 1.95 4.77 
Definitions: Opioid-free at the time of injury=no record of opioid use in the 60 days prior to injury; Long-term 
use=receiving an opioid on most days in the 90 day period after injury; TN=Tennessee; MME=morphine milligram 
equivalents 
† 
Adjusted for all variables in table 
* p<0.05 
** p<0.01 
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Figure 4.2: Receiver operating characteristic (ROC) curves of the multivariable unconditional 
logistic regression derivation and validation models.  
 
Derivation model Validation model 
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A sensitivity analysis conducted by restricting the model to people with the most 
common injury, strains, sprains, and tears, lowered the model fit to 0.885 while associations 
were unchanged except that receiving a long acting opioid within 30 days of injury in the 
validation group was higher (OR=15.7, 95% CI 9.33-26.31) than in the full sample validation 
group (OR= 3.4, 95% CI 2.93-3.95) (Supplement Table S1). However, cell sizes for long-acting 
opioid use were low in the restricted analysis (n=9 with no long-term use and 58 with long-term 
use). Additional sensitivity analyses were performed by treating MME and days’ supply of the 
first prescription as continuous variables, but they were found to have non-linear associations 
with long-term opioid use.  
Dose escalation was observed in 23.5% (n=431) of people who became long-term opioid 
users. The mean increase between the first and third months after injury was 34.04 daily MMEs 
(standard deviation 45.23, range 0.22 – 1171.43 daily MMEs). Among injured workers who 
qualified as long-term users in the first 90 days after injury, 31.5% (n=577) were still using 
opioids on most days 6 months after injury.  
Discussion  
Defining long-term opioid use as receiving an opioid for most days in a 90-day period 
captured more cases than using a 120-day period. Since TN law designates 30-day supply as the 
maximum that can be dispensed ("Prescription Safety Act of 2012," 2012), opioid users had to 
have received at least two opioid prescriptions over at least two months to surpass 45 
prescription days and meet the definition of a long-term user.  
Most (79.6%) injured workers who received opioids after injury were opioid-free at the 
time of injury, and 4% of these became long-term users. One hundred thirty-two of the long-term 
users received their first opioid more than 30 days after injury, indicating that even people who 
go a month after injury without any opioid use may still be vulnerable to opioid use or other 
injuries that may require opioid use. Notably, a third of people who qualified as long-term opioid 
users in the 90 days after injury continued to use opioids 180 days after injury. Although dose 
escalation was noted in only a quarter of long-term users, even surpassing 50 MME/day can 
increase the risk of overdose  by 30% (Dowell et al., 2016).   
Initial days’ supply was more strongly associated with long-term opioid use than MME in 
bivariable models, and continued to be a strong predictor after MME, demographic variables, 
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and other opioid use patterns were controlled for. Even receiving 5-9 days’ supply compared to 
<5 days increased the odds of long-term opioid use by 30%. Current TN prescribing guidelines 
set 7 days’ supply as a cut point for caution (Tennessee Department of Health, 2014), a threshold 
which may be too low in light of this study’s findings. This finding supports a nationwide 
study’s findings that initial days’ supply was the strongest predictor of continued opioid use 
(Shah et al., 2017). MME was associated with long-term opioid use at a lower magnitude, and 
this study showed a dose-response relationship between higher opioid doses and higher odds of 
long-term opioid use similar to that demonstrated in other research (Deyo et al., 2017).  
Six opioid use characteristics (days’ supply of first prescription, receipt of a long-acting 
opioid within 30 days of injury, overlapping opioid and benzodiazepine prescription, number of 
prescribers and pharmacies visited within 90 days of injury, and maximum MME received within 
30 days of injury) were associated with long-term opioid use in previously opioid-free injured 
workers. The strongest associations were receiving ≥20 days’ supply in the initial prescription 
(OR=10.1, 95% CI 8.21-12.47), receiving a long-acting opioid within 30 days of injury (OR=6.6, 
95% CI 5.34-8.08), visiting ≥3 prescribers (OR=6.9, 95% CI 5.82-8.23) or ≥3 pharmacies 
(OR=6.0, 95% CI 4.67-7.70) within 90 days of injury, associations which have been 
demonstrated in other populations. Injured workers who received an opioid within 7 days of 
injury had 50% lower odds (95% CI 0.45-0.53) of developing long-term opioid use than workers 
who received their first opioid more than 7 days after injury, possibly because delayed seeking of 
care may worsen injuries or treatment may be given for a subsequent, undocumented injury.   
This study identified one demographic characteristic (rural residence) associated with 
long-term use at a similar magnitude to the association demonstrated in a group of Oregon 
residents (OR=1.4, 95 % CI 1.34-1.41 for rural vs. urban) (Deyo et al., 2017). Associations 
between sex and long-term opioid use after surgery have been mixed in previous research 
(Johnson et al., 2016a; Sun et al., 2016), male sex has been shown to be associated with 
prescription opioid abuse (Rice, White, Birnbaum, Schiller, Brown et al., 2012; A. G. White, 
Birnbaum, Schiller, Tang, & Katz, 2009), and sex disparities have also been observed in drug 
treatment programs (Welty, Harrison, Abram, Olson, Aaby et al., 2016) in national samples. This 
study, however, found no association between sex and long-term opioid use and, unlike the other 
studies, did not use diagnostic records to define cases. The findings of a sex association in other 
studies may be the result of diagnostic bias for opioid misuse.   
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Previously researched associations between age and long-term opioid use have been 
similarly mixed (Edlund et al., 2007; Johnson, Chung, Zhong, Shauver, Engelsbe et al., 2016b; 
Sun et al., 2016), and this study found a positive association between middle age groups in 
bivariable analyses that nonetheless diminished model fit in multivariable analyses. This 
decrease, and the decrease observed when injury type were added, were likely the result of 
overfitting where the increase in model fit did not make up for the loss of degrees of freedom. 
Type of injury was included as a proxy for injury severity, but unchanged associations in the 
analysis of workers with strains, sprains, and tears indicate that this was not an important factor. 
Other injury groups may have more of an association, but group sizes were too small to test. 
Lower back injuries were associated with long-term opioid use.  
Addressing injury as a gateway to long-term opioid use is an important step towards 
curbing the opioid epidemic. Although previous studies have identified risk factors for the 
development of long-term opioid use, this is the first to comprehensively measure all opioid 
prescriptions, regardless of insurance or other payer source, for long-term use in injured workers. 
Additionally, this study measures long-term opioid use through prescription history, capturing 
more cases than the ICD codes used in previous research. The results of this study have high 
applicability to TN but may not be generalizable to other states. 
Limitations 
Survival bias may be present in limiting the study population to people who were opioid-
free at the time of injury. That is, people who were more likely to develop long-term opioid use 
or an opioid use disorder may have already had that outcome before the study began. As a result, 
this study measures incident cases and does not quantify how widespread long-term use is in this 
population. Effect measures apply to opioid-naïve injured workers who may develop long-term 
opioid use, not injured workers who may have long-term opioid use.   
Some people may have been classified as opioid-free due to drug diversion, i.e., taking 
opioids that were not prescribed to them. Misclassification of opioid-naivety may cause someone 
to be wrongly considered to have developed long-term opioid use after injury when in fact they 
merely switched their mechanism of obtaining opioids. In considering only new prescriptions, 
this study also misses opioids and benzodiazepines that people were previously prescribed and 
take from storage in their own medicine cabinets. Men and people with lower than $50,000 
annual income are more likely to be involved in drug diversion, which may mean that these 
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groups are more likely to be misclassified in this study and more likely to be associated with the 
development of long-term opioid use (Jones, Paulozzi, & Mack, 2014). However, research in 
other states shows that adults generally start on prescription opioids and then move to drug 
diversion when their legal supply is constrained, not vice-versa (Tedesco et al., 2017). If workers 
in this study tend to move from diverted drug sources to prescription sources, then the prevalence 
of opioid-free status would be overestimated and effect measures for opioid use variables would 
likely be underestimates. If workers tend to move from prescription drug sources to diverted 
sources, then the prevalence of long-term use would be underestimated and effect measures for 
opioid use variables would likely be underestimates. In using the CSMD to identify and measure 
opioid use this study substantially improves the accuracy of estimates made with WC records 
alone by including opioids paid for with cash and other forms of payment, regardless of claim 
approval. 
Due to limitations of the data sources, this study is not able to include several major 
predictors of opioid use disorders: mental illness, other drug use, and race and ethnicity. Due to a 
healthy worker effect, mental illness and other drug use may not cause much confounding in the 
model (Cheng et al., 2013). The effect of race and ethnicity may be a larger concern: studies in 
other states show that Whites tend to be prescribed opioids more frequently (Morden, Munson, 
Colla, Skinner, Bynum et al., 2014) and are more likely to overdose on opioids than Blacks 
(Centers for Disease Control and Prevention, 2011) but non-Whites are more likely to be 
recipients of WC (Atlas et al., 2007). Stratifying by race/ethnicity would improve the precision 
of estimates and provide more granular detail towards understanding the trends in the epidemic 
and directing resources towards groups that would benefit from increased attention, and may 
decrease the association between residence type and opioid use as Whites are more concentrated 
in rural areas of TN.  
Conclusion 
This is the first study to examine long-term opioid use in Tennessee, and among the first 
nationally to use a prescription drug monitoring program to measure long-term opioid use in 
injured workers with prescription records instead of clinical records. The development of long-
term opioid use is rare in opioid-free injured workers, but opioid use tends to be pernicious once 
established. Injury is a gateway to long-term opioid use in a vulnerable set of injured workers. 
Developing long-term use appears to be more tied to opioid prescribing than demographic 
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characteristics, especially days’ supply. This finding suggests that something about the habit or 
normalization of opioid use early in treatment sets the stage for long-term use, and that care 
should be taken to providing only a “necessary and sufficient” opioid course, if at all.  
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Chapter 5 
 Commentary on TN’s response to the opioid epidemic through the lens of these findings 
These studies provide a previously unknown picture of the prevalence, patterns, and 
outcomes of opioid use by injured workers in TN, and are among the first nationally to use a 
prescription drug monitoring program to measure opioid use in injured workers. This research 
used a novel cleaning and linkage approach to connecting statewide databases for monitoring of 
opioid use on a population level, which may be of interest to other states working with 
prescription drug monitoring programs using sources of big data that lack a unique identifier. 
The results presented here provide data-driven recommendations for vulnerable groups within 
the injured worker population as well as commentary on how opioid use in injured workers 
compares to the overall population of TN. These studies are being finalized and shared with 
stakeholders shortly after TN’s governor proposed a budget with an aggressive new plan to target 
the opioid epidemic with funding of $30 million (Tennessee Office of the Governor, January 22, 
2018).  
These findings show that while opioid use is high in TN workers after injury, high-risk 
opioid use patterns, overdose, and long-term use are low. In light of these findings, injured 
workers overall are not a population of particular concern for opioid use. Subgroups of injured 
workers receiving overlapping benzodiazepine and opioid prescriptions and prescriptions with 
long days’ supply, and chronic users who have had their prescription opioid supply constrained 
are at high risk, as are those in the U.S. population at large who have these characteristics (Rudd 
et al., 2016). If the healthy worker effect observed for opioid use and opioid outcomes extends to 
high-risk prescribing patterns, then the subgroups described above may be more prevalent in the 
general population than they are in injured workers.  
TN has made progress in reducing opioid prescribing in recent years (Tennessee 
Department of Health, Data Dashboard, also see Appendix 5: Overview of opioid-related policy 
milestones) and these studies reflect general adherence to guidelines for dose and days’ supply in 
injured workers. However, the high percentage of injured workers receiving benzodiazepines 
with opioids is cause for concern. TN chronic pain guidelines states that “benzodiazepines 
should be generally avoided in combination with chronic therapy” and advises that “when the 
opioid dose reaches 120 [MMEs] and the benzodiazepines are being used for mental health 
purposes, the provider shall refer to a mental health professional to assess the necessity of 
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benzodiazepine medication” (Tennessee Department of Health, 2014).  The prescribing 
guidelines approach concurrent use as chronic opioid use with an introduction of 
benzodiazepines, but these studies found that chronic benzodiazepine use with the introduction 
of acute opioids was more common. Attention towards this pathway may be warranted.   
TN’s Bureau of Workers’ Compensation has contributed to controls on prescribing 
through a drug formulary implemented in 2016. The formulary is more driven towards 
substituting lower cost opioids for higher cost ones than demanding non-opioid therapies, 
although it does encourage the use of short-acting formulas over long-acting. The TN 
Department of Labor also offers a discount on WC insurance to employers who are certified as 
drug free workplaces, achieved through employer-sponsored drug testing (including opioids with 
a cutoff level of >2000 ng/ml in urine)  and a zero tolerance policy towards drug use in the 
workplace (Tennessee Department of Labor). Drug testing is associated with fewer workplace 
injuries (Pidd & Roche, 2014) but may also exclude people with a drug use problem from 
participation in the workforce (Pinsker, 2015), reinforcing the healthy worker effect.   
TN’s Medicaid program has taken another approach with a pharmacy “lock in” program, 
where suspected doctor shoppers are only permitted to fill prescriptions at one pharmacy. Lock-
in programs in other states have shown that they decrease the amount of opioids that people 
receive through Medicaid, which appears to be a success until bias from migration to opioids 
paid for with cash and private insurance is considered (Dreyer, Michalski, & Williams, 2015; 
Kesselheim, Huybrechts, Choudhry, Fulchino, Isaman et al., 2015). Lock-in programs may also 
be contributing to increases in overdoses of non-prescribed opioids as opioid users turn to illicit 
markets when their legal supplies are constrained. Controls on prescribing are important to 
prevent new cases of opioid dependence, but evidence increasingly shows that this is not an 
effective solution for people who are already addicted.   
On a state population level, recent legislation has aimed at getting opioid users into 
treatment. A “Good Samaritan Law” enacted in 2014 gives civil immunity to people who 
administer naloxone (an overdose reversal drug) to another in good faith. The law also grants 
immunity from being charged with drug crimes to people who call 911 for an overdose or seek 
treatment for drug addiction. Despite these measures, overdose data show that heroin use is 
increasing, which leads to concerns about the spread of blood borne illness such as the 2016 HIV 
outbreak in Scott County Indiana fueled by injected heroin use. Syringe exchange programs were 
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legalized in TN in 2017 (T.C.A. § 68-1-136, 2017), but only two such programs have been 
established statewide since: one at a nonprofit in Nashville and one at the local Department of 
Health in Memphis (Detox local). Having exchanges at all Departments of Health throughout the 
state would increase their accessibility, make them convenient to maintain and track their usage, 
and serve as points of contact in case of an outbreak of blood borne illness. Other harm reduction 
approaches such as safe injection sites are completely absent from TN. 
Governor Haslam’s budget focuses on expanding access to narcotics treatment programs, 
which are currently inaccessible to much of the state’s population. As of spring 2018, only ten 
counties out of 95 had narcotic treatment clinics (Tennessee Department of Mental Health, 
2018). In contrast, TN had 185 registered pain clinics in 2016 (Tennessee Department of Health, 
2017). Even if treatment is accessible and affordable, however, pharmaceutical opioid treatment 
is not very effective at producing long-term abstinence. A randomized controlled trial of eight 
community-based opioid treatment centers in the U.S. found relapse rates of 57% for partial 
opioid agonist buprenorphine/naloxone to 65% for opioid antagonist naltrexone (Lee, Nunes, 
Novo, Bachrach, Bailey et al., 2018) within 24 weeks alone. Another study of outcomes 
following treatment at a residential detox clinic in Ireland found 91% of patients relapsed at 
some point after treatment, and 59% of these relapsed within the first week after discharge 
(Smyth, Barry, Keenan, & Ducray, 2010). Policy makers and funders should recognize that 
opioid use disorder, like other forms of addiction, is a chronic and relapsing disease. Improving 
access to treatment is an important part of providing people with agency and opportunities for 
healing, but relapses and non-use of treatment are facts of addiction that should be acknowledged 
and planned for.  
An overdose reversal drug, opioid-agonist naloxone that goes by the brand name Narcan, 
has been available and carried by medics for decades but only recently come into mainstream 
use. Police officers began carrying naloxone in their kits beginning in 2016 in Knoxville and 
2017 in Nashville (Allison, 2017; Naloxone Community Collaborative, 2018). Knoxville began 
tracking naloxone administration by first responders in 2017, and found that 1,200 doses of the 
lifesaving drug were given by medics, fire fighters, and police officers in the first year (Naloxone 
Community Collaborative, 2018). Naloxone is available as an over-the-counter drug and is held 
in several large chain pharmacies, but its high cost diminishes its accessibility to lay persons. 
When paid for in cash, naloxone costs $20-$40 per dose (Crowe, 2016) and multiple doses are 
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often needed to stop a single overdose (Faul, Lurie, Kinsman, Dailey, Crabaugh et al., 2017). 
Subsidizing and distributing naloxone may be an effective way for TN to apply funds towards 
lives saved.  
The studies in this dissertation support an argument that prescribing controls are working 
in TN, highlighting the importance of primary prevention. No silver bullet has been found for 
secondary and tertiary prevention of opioid substance use disorder and its effects, either for 
injured workers or the overall state population. On a population level, current best practices have 
limited effectiveness. TN has room to update prescribing guidelines with regards to overlapping 
opioid and benzodiazepine use and to improve evidence-based solutions outside of prescribing 
guidelines towards fighting the epidemic and preventing lost lives and livelihoods.  
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Appendix 1 – Forms supplying datasets used in this research 
First Report of Injury Form – Workers’ Compensation dataset 
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State of Tennessee Certificate of Death Form – Vital Statistics death certificate dataset 
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Appendix 2 – Supplemental tables from Chapter 2 Prescription opioid use by injured 
workers: A descriptive study using linked statewide databases in Tennessee. 
 
Table S2.1: Workers who reported one injury to TN Workers’ Compensation 2013-2015 
and received an opioid within 1 week, 1 month, and 6 months of injury by year and opioid-
free status at time of injury (N=172,256). P value from Cochran-Armitage test for trend. 
Opioid-free at the time of injury (n=154,636) 
Year 
Number of 
injured workers 
Received opioids 
within 1 week 
Received opioids 
within 1 month 
Received opioids 
within 6 months 
N n (%) n (%) n (%) 
2013 51589 11298 (21.9) 13824 (26.8) 15525 (30.1) 
2014 51340 11118 (21.7) 13495 (26.3) 15161 (29.5) 
2015 51707 10623 (20.5) 12952 (25.1) 14544 (28.1) 
p-value for trend  
(2 sided) 
<0.001 <0.001 <0.001 <0.001 
Not opioid-free at the time of injury (n=17,620) 
Year 
Number of 
injured workers 
Received opioids 
within 1 week 
Received opioids 
within 1 month 
Received opioids 
within 6 months 
N n (%) n (%) n (%) 
2013 6174 2244 (36.4) 3891 (63.0) 4290 (69.5) 
2014 5914 2124 (35.9) 3720 (62.9) 4110 (69.5) 
2015 5532 1814 (32.8) 3291 (59.5) 3652 (66.0) 
p-value for trend  
(2 sided) 
<0.001 <0.001 <0.001 <0.001 
Definitions: TN=Tennessee; Opioid free = no record for filling an opioid prescription in the 60 days prior to injury; 
Not opioid free = has a record for filling an opioid prescription in the 60 days prior to injury 
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Table S2.2: North American Industry Classification System (NAICS) code frequency in injured workers who 
reported one injury compared to those who reported 2 or more injuries to TN Workers’ Compensation 2013-
2015  (N=172,256) 
Industry 
Received opioid analgesics in 6 months 
No (n=114,974) n (%) Yes (n=57,282) n (%) 
Wholesale or Retail Trade 8835 (7.7) 5352 (9.3) 
Health Care and Social Assistance 9053 (7.9) 3194 (5.6) 
Manufacturing 5998 (5.2) 3167 (5.5) 
Administrative and Support and Waste 
Manage 
4355 (3.8) 2265 (4.0) 
Accommodation and Food Services 3372 (2.9) 1724 (3.0) 
Public Administration 3754 (3.3) 1314 (2.3) 
Transportation and Warehousing 2397 (2.1) 1420 (2.5) 
Construction 2069 (1.8) 1531 (2.7) 
Professional, Scientific, and Technical 
Services 
1987 (1.7) 1192 (2.1) 
Finance and Insurance 2003 (1.8) 834 (1.5) 
Information 1294 (1.1) 688 (1.2) 
Real Estate, Rental, and Leasing 1118 (1.0) 740 (1.3) 
Other Services 971 (0.8) 499 0.9) 
Management of Companies and Enterprises 828 (0.7) 421 (0.7) 
Educational Services 662 (0.6) 174 (0.3) 
Arts, Entertainment, and Recreation 511 (0.4)  243 (0.4) 
Utilities 378 (0.3) 246 (0.4) 
Mining 193 (0.2) 129 (0.2) 
Agriculture, Forestry, Fishing, and Hunting 129 (0.1) 74 (0.1) 
Missing or not in NAICS code list 65067 (56.6) 32075 (56.0) 
Definitions: TN=Tennessee; NAICS=North American Industry Classification  
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Table S2.3: Most frequently injured parts of body injured for injured workers in TN Workers’ 
Compensation Claims Database (2013-2015)  who had only one injury during the study period by 
prescription opioid use within 6 months of injury (N=172,256) 
Type of 
injury Part of body 
Workers with one injury 
(N=172,256) 
Opioid prescription filled within 6  
months of injury 
No (n=114,974) 
n (%) 
Yes (n=57,282) n 
(%) 
Other injury (n=103,492) 
 
n  % n % 
 Finger(s) 16343 11758 16.0 4585 15.2 
 Hand 10258 7419 10.1 2839 9.4 
 Multiple body parts 9235 5968 8.1 3267 10.8 
 Other part of body 67656 48239 65.8 19417 64.6 
Sprain, strain, or tear (n=60,984)      
 
Lower back 15355 9329 23.9 6026 27.4 
 
Shoulder(s) 8443 5220 13.4 3223 14.7 
 
Knee 6345 3890 10.0 2455 11.2 
 
Other part of body 30841 20557 52.7 10284 46.7 
Fracture (n=7,780)      
 
Finger(s) 1176 736 14.2 440 17.0 
 
Ankle 801 483 9.3 318 12.2 
 
Wrist 768 554 10.7 214 8.2 
 
Other part of body 5035 3412 65.8 1623 62.6 
Definitions: TN=Tennessee 
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Table S2.4: Estimated crude and adjusted associations (prevalence ratios [PRs] and 95% confidence intervals 
[CIs]) of demographic characteristics and type of injury with receiving an opioid within 6 months of injury in 
workers who reported one injury to TN Workers’ Compensation 2013-2015 (N=172,256): Results from 
Poisson regression analyses 
Characteristic 
Opioid prescription filled within 6 
months of injury 
Unadjusted PR (95% 
CI) 
Adjusted
†
 PR
 
(95% CI) 
No (n=114,974) 
n (%) 
Yes (n=57,282) 
n (%) 
n (%) n (%)   
Age, years     
15 - 34 47892 (41.7) 18538 (32.4) 1.0 (ref) 1.0 (ref) 
35 - 54 47652 (41.4) 27219 (47.5) 1.3 (1.28-1.33) 1.2 (1.18-1.22) 
55 - 99 19430 (16.9) 11525 (20.1) 1.3 (1.30-1.37) 1.2 (1.17-1.23) 
Sex     
Female 52070 (45.3) 24924 (43.5) 1.0 (ref) 1.0 (ref) 
Male 62904 (54.7) 32358 (56.5) 1.05 (1.03-1.07) 
1.1 (1.07-1.11) 
 
Type of injury     
Other 73383 (63.8) 30109 (52.6) 1.0 (ref) 1.0 (ref) 
Strain, sprain, or tear 38996 (33.9) 21988 (38.4) 1.2 (1.22-1.26) 1.2 (1.13-1.18) 
Fracture 2595 (2.3) 5185 (9.0) 2.3 (2.22-2.36) 2.3 (2.20-2.33) 
Part of body      
Other 67374 (58.6) 32180 (56.2) 1.0 (ref) 1.0 (ref) 
Finger(s) 12773 (11.1) 5498 (9.6) 0.9 (0.90-0.96) 1.0 (0.97-1.03) 
Lower back 10660 (9.3) 7005 ((12.2) 1.2 (1.19-1.26) 1.2 (1.16-1.23) 
   Multiple body parts 7847 (6.8) 4680 (8.2) 1.2 (1.12-1.19) 1.2 (1.14-1.22) 
Hand 8705 ((7.6) 3466 (6.0) 0.9 (0.85-0.91) 0.95 (0.92-0.99) 
Knee 7615 (6.6) 4453 (7.8) 1.1 (1.11-1.18) 1.1 (1.10-1.18) 
Geographical area     
   East 41538 (36.1) 20426 (35.7) 1.0 (ref) 1.0 (ref) 
   Middle 49784 (43.3) 23505 (41.0) 0.97 (0.95-0.99) 1.0 (0.97-1.01) 
   West 23652 (20.6) 13351 (23.3) 1.1 (1.07-1.12) 1.1 (1.09-1.14) 
Prior opioid use 5568 (4.8) 12052 (21.0) 2.3 (2.29-2.39) 2.3 (2.24-2.33) 
Definitions: TN=Tennessee; PR=prevalence ratio; CI=confidence interval 
†
Adjusted prevalence ratios control for all variables in table and age*prior opioid use interaction 
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Appendix 3 – Supplemental tables from Chapter 3 Patterns of prescription opioid use 
associated with nonfatal opioid overdose: A case-control study using linked statewide 
databases in Tennessee. 
 
Table S3.1: Classification of comorbidities using Hospital Discharge Data Set 
Comorbidity ICD-9 ICD-10 
Cancer Diag(i) in: 
('140','141','142','143','144','145','146','147','
148','149','150','151','152','153', 
                         
'154','155','156','157','158','159','160','161','1
62','163','164','165','170','171', 
                         
'172','174','175','176','179','180','181','182','1
83','184','185','186','187','188', 
                         
'189','190','191','192','193','194','195','200','2
01','202','203','204','205','206', 
                         '207','208','2386') 
Diag(i) in: 
('C00','C01','C02','C03','C04','C05','C06','C0
7','C08','C09','C10','C11', 
                         
'C12','C13','C14','C15','C16','C17','C18','C19
','C20','C21','C22','C23', 
                         
'C24','C25','C26','C30','C31','C32','C33','C34
','C37','C38','C39','C40', 
                         
'C41','C43','C45','C46','C47','C48','C49','C50
','C51','C52','C53','C54', 
                         
'C55','C56','C57','C58','C60','C61','C62','C63
','C64','C65','C66','C67', 
                         
'C68','C69','C70','C71','C72','C73','C74','C75
','C76','C81','C82','C83', 
                         
'C84','C85','C88','C90','C91','C92','C93','C94
','C95','C96','C97') 
Substance use 
disorder (SUD)
 
substr(Diag(i),1,3) in ('291' '292' '303' '304' 
'305' '571')   
or substr(Diag(i),1,4) in ('3575' '5353')  
or substr(Ecode1,1,4) eq ('E860.0') 
substr(Diag(i),1,3) in ('F10' 'F11' 'F12' 'F13' 
'F14' 'F15' 'F16' 'F17' 'F18' 'F19') 
Anxiety disorder 
substr(Diag(i),1,5) in ('30000' '30001' 
'30002') 
substr(Diag(i),1,3) in ('F41') 
Depression 
substr(Diag(i),1,4) in ('2962' '2963' '2980' 
'3090' '3091')   
or substr(Diag(i),1,3) eq '311' 
substr(Diag(i),1,3) in ('F33' 'F32') 
Bipolar/psychotic 
disorder 
substr(Diag(i),1,3) in ('291' '292' '293' '294' 
'295' '296' '297' '298' '299' '301' '306')   
substr(Diag(i),1,3) in ('F20' 'F21' 'F22' 'F23' 
'F24' 'F25' 'F26' 'F27' 'F28' 'F29' 'F60' 'F61' 
'F62' 'F63' 'F64' 'F65' 'F66' 'F67' 'F68' 'F69')   
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Table S3.2: Most frequent causes of hospitalization among injured workers who reported one injury to TN 
Workers’ Compensation 2013 (N=84054), by age group 
Age 15-29 years Age 30-59 years Age 60-99 years 
Primary 
diagnosis 
n % 
Primary 
diagnosis 
n % 
Primary 
diagnosis 
n % 
Abdominal pain 2700 2.8 Chest pain 9031 4.5 Chest pain 899 3.3 
Chest pain 2167 2.2 
Abdominal 
pain 
4508 2.3 
Screening for 
malignant 
neoplasms of 
colon 
642 2.3 
Urinary tract 
infection 
2136 2.2 Headache 3715 1.9 
Atherosclerotic 
heart disease 
343 1.2 
Headache 2059 2.1 Lumbago 2434 1.2 Abdominal pain 263 1.0 
Pregnancy 
complication 
1734 1.8 
Urinary tract 
infection 
2198 1.1 
Urinary tract 
infection 
233 0.9 
Acute upper 
respiratory 
infection 
1352 1.4 Low back pain 2085 1.1 Headache 210 0.8 
Pharyngitis 1142 1.2 
Acute 
bronchitis 
2078 1.0 Lumbago 196 0.7 
Acute bronchitis 1073 1.1 
Acute upper 
respiratory 
infection 
1531 0.8 Low back pain 160 0.6 
Nausea with 
vomiting 
1032 1.1 Lumbar sprain 1222 0.6 Hypertension 138 0.5 
Low back strain 951 1.0 
Nausea with 
vomiting 
1193 0.6 Osteoarthritis 131 0.5 
Lumbago 837 0.9 
Pain in joint, 
lower leg 
1109 0.6 Shoulder pain 133 0.5 
Low back pain 774 0.8 Shoulder pain 1121 0.6 Pneumonia 128 0.5 
Neck sprain 549 0.6 
Screening for 
malignant 
neoplasms of 
colon 
1070 0.5 
Rotator cuff 
sprain 
128 0.5 
Ankle sprain 537 0.6 Neck sprain 1058 0.5 
Pain in joint, 
lower leg 
127 0.5 
All others 78126 80.4  All others 164838 82.8 All others  23782 86.4 
Definitions: TN=Tennessee 
Injured workers may appear in more than one category 
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Appendix 4 – Supplemental tables from Chapter 4 A predictive model for injury as a 
gateway to long-term opioid use: A retrospective cohort study using linked statewide 
databases in Tennessee. 
 
Table S4.1: Comparing definitions for long-term opioid use in injured workers who were opioid-free before 
injury and received opioids within 90 days of injury (N=46399) 
Definition 
Received an opioid within 30 days of injury 
(n=38080) 
Received an opioid within 90 days of injury 
(n=46399) 
n captured 
by this 
definition 
(%) 
n captured 
only by this 
definition (%) 
n captured by 
both 
definitions 
(%) 
n captured 
by this 
definition 
n captured 
only by this 
definition 
n captured by 
both 
definitions 
Definition 1: 
Receiving an 
opioid on ≥45 
days in a 90 day 
period 
1702 (4.5) 512 (1.3) 
1190 (3.1) 
1834 (4.0) 540 (1.2) 
1294 (2.8) 
Definition 2: 
Receiving an 
opioid on ≥60 
days in a 120 day 
period 
1416 (3.7) 226 (0.6) 1612 (3.5)  318 (0.7) 
Opioid-free at the time of injury=no record of opioid use in the 60 days prior to injury 
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Table S4.2: Baseline and clinical characteristics of injured workers who reported one injury to Tennessee 
Workers’ Compensation, were opioid-free at the time of injury, and received opioids within 90 days of injury 
(N=55,656), by model and long-term use  
Characteristic 
Derivation Model Validation model 
Long-term opioid use Long-term opioid use 
No (n=29347) Yes(n=1261) No (n=15218) Yes (n=573) 
n % n % n % n % 
Age (years)         
15 - 34 10380 35.4 283 22.4 5437 35.7 113 19.7 
35-54 13433 45.8 688 54.6 6753 44.4 321 56.0 
55-99 5534 18.9 290 23.0 3028 19.9 139 24.3 
Type of injury         
Strain, sprain, or tear 11397 38.8 597 47.3 5588 36.7 251 43.8 
Fracture 2559 8.7 196 15.5 1498 9.8 98 17.1 
Other 15391 52.4 468 37.1 8132 53.4 224 39.1 
Part of body injured         
Lower back 3480 11.9 243 19.3 1685 11.1 106 18.5 
Finger(s) 3062 10.4 56 4.4 1498 9.8 26 4.5 
Knee 2363 8.1 102 8.1 1201 7.9 45 7.9 
Other 20442 69.7 860 68.2 10834 71.2 396 69.1 
Residence type         
Urban 11294 38.5 387 30.7 5768 37.9 176 30.7 
Rural 18053 61.5 874 69.3 9450 62.1 397 69.3 
Opioid received within 7 days of injury 19789 67.4 868 68.8 10225 67.2 398 69.5 
Days’ supply of first prescription         
     <5 17180 58.5 245 19.4 9085 59.7 135 23.54 
5-9 8276 28.2 159 12.6 4162 27.35 86 14.93 
10-19 2407 8.2 148 11.8 1126 7.4 71 12.42 
≥20 393 1.4 105 8.3 228 1.5 45 7.85 
Long-acting opioid received within 30 
days of injury 
149 0.5 101 8.0 75 0.5 39 6.8 
Overlapping opioid and benzodiazepine 
prescription days within 30 days of injury 
1015 3.5 151 12.0 586 3.9 56 9.8 
Number of prescribers visited for opioids 
within 90 days of injury 
                
   1 21010 71.6 261 20.7 10846 71.3 106 18.5 
   2 6240 21.3 407 32.3 3197 21.0 173 30.2 
   ≥3 2097 7.1 593 47.0 1175 7.7 294 51.3 
Number of pharmacies visited for opioids 
within 90 days of injury 
                
   1 25102 85.5 545 43.2 13112 86.2 267 46.6 
   2 3555 12.1 434 34.4 1800 11.8 203 35.4 
   ≥3 690 2.4 282 22.4 306 2.0 103 18.0 
Maximum MME received within 30 days 
of injury 
        
   <40 10565 36.0 436 34.6 5433 35.7 5144 33.8 
   40-99 10037 34.2 477 37.8 5265 34.6 5707 37.5 
   100-159 4549 15.5 207 16.4 2328 15.3 2557 16.8 
≥160 4197 14.3 141 11.2 2191 14.4 1811 11.9 
Definitions: Opioid-free at the time of injury=no record of opioid use in the 60 days prior to injury; Long-term 
use=receiving an opioid on most days in the 90 day period after injury; MME=morphine milligram equivalents 
*All comparisons between non opioid free and opioid free injured workers were significantly different at p<0.05 
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Table S4.3: Estimated crude associations (odds ratios [ORs] and 95% confidence intervals [CIs]) of 
demographic, injury, and opioid use variables with long-term opioid use after injury in injured workers who 
reported one injury to Tennessee Workers’ Compensation and were opioid-free at the time of injury: Results 
from unconditional logistic regression analyses.  
Characteristic 
Derivation Model (N=30,608) 
Unadjusted OR 
95% CI 
lower upper 
Part of body injured       
Other ref      
Lower back 1.7** 1.43 1.92 
Finger(s) 0.4** 0.33 0.57 
Knee 1.0 0.83 1.27 
Residence type    
Urban ref   
Rural 1.3** 1.26 1.40 
Opioid received within 7 days of injury 1.1 0.95 1.21 
Days’ supply of first prescription, dummy variables    
     <5 ref   
5-9 3.2* 2.80 3.63 
10-19 6.8* 5.86 7.96 
≥20 36.6* 33.33 40.16 
Long-acting opioid received within 30 days of injury 25.6* 21.80 29.98 
Overlapping opioid and benzodiazepine prescription days within 
30 days of injury 
7.8* 7.19 8.44 
Number of prescribers visited for opioids within 90 days of injury       
   1 ref     
   2 2.5* 2.31 2.66 
   ≥3 9.1* 8.13 10.25 
Number of pharmacies visited for opioids within 90 days of 
injury 
      
   1 ref     
   2 2.9* 2.70 3.12 
   ≥3 11.6* 9.61 14.05 
Maximum MME received within 90 days of injury       
   <40 1.9* 1.73 2.03 
   40-99 2.2* 2.02 2.41 
100-159 3.7* 3.29 4.22 
 ≥160 1.5* 1.24 1.75 
Definitions: Opioid-free at the time of injury=no record of opioid use in the 60 days prior to injury; Long-term 
use=receiving an opioid on most days in the 90 day period after injury; OR=odds ratio; CI=confidence interval 
* p<0.05 
** p<0.01 
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Appendix 5: Overview of opioid-related policy milestones in Tennessee 
2018 
 Governor Haslam announces $30 million to be applied towards prevention, treatment, 
and law enforcement aimed at opioid addiction. Specific components include limiting the 
state Medicaid’s coverage of opioids, targeted outreach towards chronic opioid users who 
are women of childbearing age, $25 million towards treatment and recovery services 
including within the criminal justice system, improving the state’s data systems to track 
the epidemic, and prosecuting the illicit sale and trafficking of opioids.  
2016 
 Prescription Safety Act of 2016 –The period allowed between dispensing a controlled 
substance and reporting it to the CSMD is decreased to “close of business day” for 
human patients, and certain law enforcement personnel are granted access to the CSMD.  
 Public Chapter 820 of 2014, the “Fetal Assault Law”, expires. 
2015 
 Public Chapter 26 – The Intractable Pain Act, which had provided a “Pain Patient’s Bill 
of Rights” virtually guaranteeing access to opioids for patients who requested it, is 
deleted. 
 Public Chapter 475 – Pain clinic certificates can only be held by a TN licensed doctor, 
advanced practice nurse, or physician’s assistant who is a pain medicine specialist. 
Certificate holders must own the pain clinic for which they hold the certificate.  
 Public Chapter 396 update – The Addiction Treatment Act of 2015 and “Good Samaritan 
naloxone law” which prevents criminal drug charges (e.g. violation of probation or 
parole) from being filed against a person who is experiencing a drug overdose or is in the 
company of a person who is experiencing a drug overdose and who seeks medical 
assistance, and limits buprenorphine prescribing.  
2014 
 Chronic Pain Guidelines define appropriate measures for treating chronic pain and set 
thresholds for opioid use that warrant referral to a pain specialist.  
 Public Chapter 820 – The “Fetal Assault Law” allows for mothers to be charged with 
criminal assault for giving birth to babies with Neonatal Abstinence Syndrome. 
2013 
 Neonatal Abstinence Syndrome is made a reportable disease and cross-state surveillance 
begins.  
 Public Chapter 396 – Tennessee Department of Health is required to annually identify the 
top 50 prescribers of controlled substances in the state, notify them of their inclusion of 
the list, request a justification for their prescribing patterns, and provide disciplinary 
action for failing to provide a justification. Schedule II and III drugs may not be 
dispensed in greater than 30 day supplies. 
2012 
 Prescription Safety Act of 2012 – Prescribers must check the Controlled Substances 
Monitoring Database before prescribing an opioid in a majority of cases of pain and 
routinely for patients with chronic opioid use 
2006 (December) 
 Reporting to the Controlled Substances Monitoring Database is required for pharmacists 
and other dispensers.  
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